Use of other anti-dementia drugs

ADMED_OTHER_ANTI_DEMENTIA_DRUGS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06DX 1 out of 7 registries used, show all original rules.	16062
4. Check minimum number of events Min. number of events 3	16062
5. Include endpoints None	16062
6. Filter based on genotype QC (FinnGen only)	14161

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ADMED_OTHER_ANTI_DEMENTIA_DRUGS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06DX
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Use of other anti-dementia drugs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Use of memantine

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14161	7047	7114
Unadjusted period prevalence (%)	2.88	2.50	3.26
Median age at first event (years)	80.94	81.20	80.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14193: Matched controls
114192

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F05.1

ICD-10 Finland

Delirium superimposed on dementia

8.3

317.0

467

465

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.3

307.7

4432

8997

F0019, G301,

ICD-10 Finland

9.7

307.7

439

374

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

4821

22511

N06DA02

ATC

donepezil; oral

20.1

307.7

6510

4624

N06DA04

ATC

galantamine; oral

11.9

307.7

2048

1599

SPAT1254

SPAT

Administration of medicine

2.6

307.7

3772

14194

P20

ICPC

Memory disturbance

9.8

307.7

8646

15737

N06DX01

ATC

memantine; oral

+∞

307.7

14193

1642

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.4

307.7

3153

8890

A28

ICPC

Limited function/disability NOS

3.1

307.7

6226

23221

G30

ICD-10 Finland

Alzheimer disease

22.2

307.7

1194

470

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

17.3

307.7

663

322

SPAT1245

SPAT

Provision of support and information to patient’s family members

4.6

307.7

2006

3956

P70

ICPC

Dementia

16.3

307.7

2359

1379

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

307.7

3898

16451

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

16.8

307.7

3980

2583

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.3

307.7

2463

6843

G30.1

ICD-10 Finland

Alzheimer disease with late onset

31.3

307.7

7822

4315

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

24.7

307.7

1236

440

N05AH04

ATC

quetiapine; oral

3.9

307.7

3478

8700

N05AX08

ATC

risperidone; systemic

9.5

307.7

4716

5707

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.5

307.7

4081

15900

R41.3

ICD-10 Finland

Other amnesia

4.3

307.7

1148

2285

SPAT1053

SPAT

Memory test

4.8

307.7

6561

17427

SPAT1216

SPAT

Assessment of functional ability

2.9

307.7

4737

16724

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

19.8

307.7

3900

2148

G30.8

ICD-10 Finland

Other Alzheimer disease

14.8

307.7

2388

1542

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

14.8

307.7

2413

1556

SPAT1234

SPAT

Support of social functional capacity

4.0

307.7

2036

4579

WYA20

NOMESCO Finland

Home visit

5.7

307.7

884

1326

N06DA03

ATC

rivastigmine; oral, transdermal

13.9

307.7

4229

3378

N05BA04

ATC

oxazepam; oral

2.5

307.7

4939

20393

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

27.0

307.7

617

192

G30.0

ICD-10 Finland

Alzheimer disease with early onset

21.7

307.7

771

301

F06.7

ICD-10 Finland

Mild cognitive disorder

4.5

307.7

1391

2679

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

25.7

307.7

4104

1779

F03

ICD-10 Finland

Unspecified dementia

4.8

307.7

2445

4731

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

23.5

307.7

522

185

N06AX26

ATC

vortioxetine; oral

3.7

300.5

1061

2414

N02BE01

ATC

paracetamol; systemic, rectal

2.9

300.1

12879

88198

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

292.2

6261

33215

N02AA05

ATC

oxycodone; systemic

2.0

286.5

4312

20218

N06AX11

ATC

mirtazapine; oral

2.0

286.2

5254

26408

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

38.7

279.7

204

L28

ICPC

Limited function/disability (L)

2.0

271.5

4470

21555

SPAT1301

SPAT

No procedures

1.9

263.6

5625

29513

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

261.7

2632

10510

SPAT1304

SPAT

Counselling and guidance related to ageing

2.3

254.1

2321

8887

AA1AD

NOMESCO Finland

CT of head and brain

1.8

247.5

5855

31563

AXX01, ,

SPAT

3.0

247.0

1229

3469

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

244.7

4748

24018

A04

ICPC

Weakness/tiredness general

2.1

243.5

3183

14043

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

28.0

238.2

189

SPAT1101

SPAT

Orthostatic test

2.7

224.0

1336

4160

U04

ICPC

Incontinence urine

2.5

212.7

1579

5477

N06AB10

ATC

escitalopram; oral

2.2

212.4

2170

8655

N03AG01

ATC

valproic acid; systemic, rectal

3.1

204.2

941

2531

R41.0

ICD-10 Finland

Disorientation, unspecified

3.0

200.4

1012

2871

SPAT1252

SPAT

Overall medication plan or its review

2.4

196.8

1638

5976

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.2

195.8

2033

8141

A98

ICPC

Health maint/preventive medicine

2.1

193.7

12325

86417

N05AH03

ATC

olanzapine; systemic

3.3

189.9

804

2051

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

4.1

187.0

558

1116

F009, G309,

ICD-10 Finland

9.4

183.4

244

211

SPAT1360

SPAT

Extensive global examination

2.4

178.2

1461

5283

SPAT1172

SPAT

Guidance concerning hydration

3.1

172.2

802

2166

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

24.2

168.5

140

TAB00

NOMESCO Finland

Lumbar puncture

3.5

165.1

631

1505

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.2

165.0

483

951

N05AD01

ATC

haloperidol; systemic

3.0

156.0

774

2167

F00

ICD-10 Finland

Dementia in Alzheimer disease

10.9

155.9

188

140

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

155.5

1209

4258

SPAT1263

SPAT

Sampling

1.6

146.2

6010

36038

A29

ICPC

General symptom/complaint other

1.8

142.6

2478

11790

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

35.1

139.4

104

F0014, G301,

ICD-10 Finland

16.0

138.9

136

SPAT1229

SPAT

Assessment of need for aid

2.0

136.3

1735

7433

F001, G301,

ICD-10 Finland

15.9

129.1

127

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

128.2

1134

4214

SPAT1139

SPAT

Nutrition survey

2.7

127.8

738

2242

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

126.8

4585

26433

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

17.4

125.2

118

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

123.7

1022

3686

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

121.7

1281

5104

130

Kela drug reimbursment

Malignant tumour

0.3

120.1

316

8581

F21, ,

ICPC

4.5

119.1

314

568

A06AD11

ATC

lactulose; oral

1.6

118.5

3225

17297

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

115.0

1736

7853

ICB01, ,

SPAT

7.6

114.8

179

191

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.5

113.8

813

2743

S01.0

ICD-10 Finland

Open wound of scalp

2.0

113.1

1505

6524

OAB76

NOMESCO Finland

General guidance on nutrition and food

8.1

111.6

166

167

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

111.1

1653

7437

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

4.1

110.4

333

670

J01CA08

ATC

pivmecillinam; oral

1.5

110.0

5157

31244

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

108.0

1144

4561

R55

ICD-10 Finland

Syncope and collapse

1.7

107.5

2250

11217

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.9

107.4

1474

6451

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

107.2

2950

15809

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

106.0

2547

13176

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

4.7

105.8

265

459

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

102.5

4614

27612

XA800

NOMESCO Finland

Neuropsychological investigation

3.1

100.8

453

1194

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

99.7

2682

14257

F0011, G301,

ICD-10 Finland

21.5

98.2

S06.0

ICD-10 Finland

Concussion

1.8

96.3

1602

7446

SPAT1167

SPAT

Insertion of urinary catheter

2.3

95.9

834

3067

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.9

94.0

1456

6616

N06AB06

ATC

sertraline; oral

2.0

93.6

1088

4483

W19

ICD-10 Finland

Unspecified fall

1.8

91.5

1675

8005

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

91.2

967

3849

F0009, G300,

ICD-10 Finland

8.7

90.7

127

118

Z29

ICPC

Social problem NOS

3.2

90.1

390

1004

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

88.3

2847

15746

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

86.7

2896

32291

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

5.1

85.8

195

310

AXX01

NOMESCO Finland

Memory assessment

4.4

82.9

225

417

C10AA01

ATC

simvastatin; oral

1.4

82.4

7775

52751

H02AB02

ATC

dexamethasone; systemic

0.4

81.7

409

8180

J01DB01

ATC

cefalexin; oral

1.5

80.7

10430

74733

N30.0

ICD-10 Finland

Acute cystitis

1.6

80.1

2596

14336

SPAT1050

SPAT

Extensive neurological examination

2.8

79.7

422

1221

R42

ICD-10 Finland

Dizziness and giddiness

1.5

79.1

3944

23811

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

23.9

77.9

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

4.8

77.8

189

319

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

76.8

562

1913

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

16.0

76.6

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.3

74.4

618

2225

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

72.7

4957

31566

R5110, ,

SPAT

1.7

71.3

1563

7823

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

31.1

70.1

OAB48

NOMESCO Finland

Lifestyle advice and guidance

5.9

69.3

135

185

E0000UV, ,

ATC

1.4

67.5

5172

33473

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

67.0

1031

4654

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

63.4

1469

17983

S70.0

ICD-10 Finland

Contusion of hip

2.0

62.5

761

3177

R1250

NOMESCO Finland

Evaluation of functional capability

2.6

62.1

390

1233

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.8

62.1

330

957

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

59.9

1224

15464

WYA20, ,

SPAT

3.7

59.1

198

431

IHZ08, ,

SPAT

5.0

58.8

136

220

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

58.5

1603

8459

F01.2

ICD-10 Finland

Subcortical vascular dementia

3.7

55.0

184

400

SPAT1251

SPAT

Organisation of medication

2.0

54.4

669

2801

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

21.1

53.8

F0029, G308,

ICD-10 Finland

7.1

53.7

100

AA1CG, ,

SPAT

4.1

53.5

159

317

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

26.7

53.3

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

52.5

1003

4817

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

20.6

52.3

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

52.1

5581

37554

W0A10

NOMESCO Finland

Mapping of psychosocial situation

8.1

51.4

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

17.6

51.2

A04AA02

ATC

granisetron; systemic, transdermal

0.3

50.5

150

3880

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

8.4

50.3

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

50.3

474

1797

J01EA01

ATC

trimethoprim; systemic

1.4

49.7

3705

23594

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

14.9

49.5

SPAT1014

SPAT

Treatment of eyes

2.4

49.3

362

1233

SPAT1310

SPAT

Counselling related to known health issue

1.3

49.2

3986

25697

SPAT1262

SPAT

Handing over of treatment supplies

1.4

48.6

2558

15375

F002, G308,

ICD-10 Finland

13.7

48.4

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.1

48.3

483

1873

SPAT1125

SPAT

Stoma care and guidance

2.3

48.1

399

1435

E86

ICD-10 Finland

Volume depletion

2.0

47.5

540

2197

SPAT1260

SPAT

Consultation of another employee

1.4

47.5

2391

14250

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

47.2

3917

25313

TQW40, ,

SPAT

0.5

46.9

357

6098

P05

ICPC

Senility, feeling/behaving old

3.6

46.5

162

363

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

46.4

6202

42773

N06AB04

ATC

citalopram; systemic

1.4

46.1

2440

14665

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

45.3

3228

20361

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

3.5

44.8

164

380

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

44.2

1657

9329

WZC30

NOMESCO Finland

Teaching

0.6

44.1

972

12151

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

43.6

2723

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

43.4

340

1193

WX402

NOMESCO Finland

General anaesthesia

0.6

43.4

1088

13212

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

42.7

1080

5572

R1210, ,

SPAT

4.1

42.6

127

254

N27

ICPC

Fear of neurological disease other

2.3

42.6

331

1157

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

42.5

2266

13616

F0012, G301,

ICD-10 Finland

15.4

42.2

WPA10, ,

SPAT

5.0

42.0

157

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.5

41.7

273

882

SPAT1325

SPAT

Vaccination

1.3

41.5

5266

35907

Z28

ICPC

Limited function/disability (Z)

3.9

41.4

131

274

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

41.2

5331

36425

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

13.9

41.0

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

40.8

388

1476

JN4AD

NOMESCO Finland

Body CT examination

0.6

40.4

807

10343

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.3

40.3

314

1099

P29

ICPC

Psychological sympt/compl other

2.1

40.1

411

1609

AA1AD, ,

SPAT

3.1

39.6

174

453

N17

ICPC

Vertigo/dizziness

1.4

39.5

1996

11869

KMAK, ,

NOMESCO Finland

1.3

39.2

4632

31236

G04BD12

ATC

mirabegron; oral

1.4

38.9

2007

11971

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

38.9

2619

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

38.9

1350

7471

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

38.7

4706

31836

-2, ,

ICPC

3.5

38.5

142

331

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

38.5

760

3678

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

37.9

1969

11755

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

37.7

6898

48960

Z75.5

ICD-10 Finland

Holiday relief care

2.6

37.2

221

681

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.3

37.0

100

2721

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.2

36.5

332

1241

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

36.3

447

1871

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

36.3

2644

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

36.2

387

1541

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.8

36.1

527

2333

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

36.0

1569

9070

F0024, G308,

ICD-10 Finland

12.4

35.9

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

12.4

35.9

SPAT1284

SPAT

Extensive health certificate

2.2

35.1

308

1135

P04

ICPC

Feeling/behaving irritable/angry

5.9

34.8

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.0

34.3

389

1583

XQ855, ,

SPAT

2.7

34.1

196

594

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

33.9

924

4846

M04AA01

ATC

allopurinol; systemic

0.7

33.8

1412

15584

A04AA01

ATC

ondansetron; systemic, rectal

0.5

33.4

356

5439

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.0

33.3

408

1706

SPAT1236

SPAT

Informing family of child’s disability

2.2

32.6

290

1075

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

31.7

5565

39032

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.9

31.5

397

1676

G04CB01

ATC

finasteride; oral

1.3

31.5

2263

14190

R1250, ,

SPAT

1.9

31.4

411

1757

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.1

31.4

1550

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.4

31.3

219

731

K02.1

ICD-10 Finland

Caries of dentine

1.2

31.1

5246

36610

EBA00

NOMESCO Finland

Extraction of tooth

1.3

30.9

3681

24678

SPAT1097

SPAT

Recording of ECG

1.3

30.8

2151

13427

AA1BG, ,

SPAT

2.5

30.8

206

674

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.6

30.7

513

6893

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

30.6

478

2163

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

14.7

30.4

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

3.7

30.3

102

224

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.2

30.2

1650

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

29.8

215

728

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.0

29.8

349

1436

SPAT1111

SPAT

Planning of analgesia

2.5

29.7

188

599

W06

ICD-10 Finland

Fall involving bed

2.5

29.6

196

638

XQ858, ,

SPAT

3.2

29.4

125

320

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.7

29.1

631

3128

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

28.8

883

10348

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

28.4

1201

6892

C03DA01

ATC

spironolactone; oral

0.7

28.2

1287

14039

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

8.5

28.2

Z51.5

ICD-10 Finland

Palliative care

1.4

27.9

1654

10055

A11CC03

ATC

alfacalcidol; systemic

0.2

27.9

1643

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

27.7

1663

17383

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

27.7

424

1907

L75

ICPC

Fracture: femur

2.1

27.7

287

1131

EB4VA, ,

NOMESCO Finland

0.5

27.5

342

4992

N29

ICPC

Neurological sympt/complt other

2.1

27.3

275

1071

A01

ICPC

Pain general/multiple sites

1.4

27.0

1319

7766

C10AX09

ATC

ezetimibe; oral

0.7

26.9

1183

12995

G31.0

ICD-10 Finland

Circumscribed brain atrophy

3.3

26.9

109

271

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

26.8

1063

11882

A27

ICPC

Fear of other disease NOS

1.6

26.7

705

3669

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

26.6

440

2025

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

3.4

26.4

100

238

SPAT1281

SPAT

Other administrative function

1.5

26.3

922

5102

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

26.2

666

3435

XF600, ,

SPAT

1.7

26.2

537

2625

P28

ICPC

Limited function/disability (P)

3.5

25.9

210

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

25.7

407

1850

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

25.7

1930

12148

Z03

ICPC

Housing/neighbourhood problem

3.1

25.6

111

288

J01CA04

ATC

amoxicillin; systemic

1.2

25.6

9382

70246

XF606, ,

SPAT

2.6

25.5

154

480

N02AJ06

ATC

codeine and paracetamol; systemic

0.8

25.3

3215

30593

K08.3

ICD-10 Finland

Retained dental root

1.5

25.3

950

5328

SPAT1138

SPAT

Guidance concerning bowel function

2.1

25.1

258

1013

A78

ICPC

Infectious disease other/NOS

2.6

25.1

154

484

S00.0

ICD-10 Finland

Superficial injury of scalp

1.8

24.7

364

1618

N28

ICPC

Limited function/disability (N)

2.0

24.7

262

1042

F00, F03,

ICD-10 Finland

6.3

24.6

HA1RA, ,

SPAT

0.2

24.5

1580

L01BC06

ATC

capecitabine; oral

0.4

24.5

119

2433

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

24.4

943

5315

ZYB04, ,

SPAT

3.8

24.2

170

J96.1

ICD-10 Finland

Chronic respiratory failure

0.3

24.1

2064

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

24.1

231

3655

M02AA07

ATC

piroxicam; topical

1.2

23.9

4757

33510

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

23.8

3579

24498

I50.1

ICD-10 Finland

Left ventricular failure

0.6

23.7

443

5796

ZX120

NOMESCO Finland

Intravenous

0.6

23.6

571

7044

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

23.5

917

5180

EB1VA, ,

NOMESCO Finland

0.7

23.5

713

8387

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

23.4

5947

42842

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

23.4

2407

23502

SPAT1104

SPAT

Monitoring of emergency patient

1.5

23.4

864

4828

R06.0

ICD-10 Finland

Dyspnoea

0.8

23.3

2913

27822

J01MA02

ATC

ciprofloxacin; systemic

1.2

23.2

5377

38394

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

23.1

608

7368

F01

ICD-10 Finland

Vascular dementia

3.0

23.1

106

285

F0013, G301,

ICD-10 Finland

24.9

23.1

LAITO, ,

NOMESCO Finland

5.6

23.0

SPAT1285

SPAT

Provision of consultation response

1.5

22.9

663

3520

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

22.9

442

2125

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.3

22.9

1683

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.2

22.9

197

722

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

7.0

22.9

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

22.9

1450

15080

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

22.5

362

1654

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

31.2

22.3

N06AX16

ATC

venlafaxine; oral

1.4

22.2

942

5402

S01.8

ICD-10 Finland

Open wound of other parts of head

2.1

22.2

222

864

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

22.1

513

2589

SPAT1255

SPAT

Intravenous administration of medicine

1.4

22.0

881

4998

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

22.0

701

3801

WW500

NOMESCO Finland

Blood transfusion

0.5

21.9

176

2957

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

21.6

684

7987

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.2

21.1

1067

F32

ICD-10 Finland

Depressive episode

1.8

21.0

330

1498

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

20.9

635

3407

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

20.9

9621

72745

L03AA13

ATC

pegfilgrastim; parenteral

0.4

20.8

113

2202

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.1

20.8

214

843

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.6

20.7

317

4364

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

20.6

477

2405

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

20.6

6775

49723

G03CA04

ATC

estriol; systemic, vaginal

1.3

20.5

1260

7687

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.3

20.3

1737

G04CB02

ATC

dutasteride; oral

1.3

20.3

1322

8134

JN4BD

NOMESCO Finland

Extensive body CT

0.7

20.2

813

9093

ZX120, ,

SPAT

2.1

20.1

197

761

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.0

20.1

239

G04BD08

ATC

solifenacin; oral

1.4

19.9

1022

6059

R54

ICD-10 Finland

Senility

2.5

19.9

132

432

D12

ICPC

Constipation

1.5

19.7

577

3072

G04CA02

ATC

tamsulosin; oral

1.2

19.3

4143

29240

R01AD59

ATC

mometasone, combinations; nasal

0.3

18.9

1369

S09.9

ICD-10 Finland

Unspecified injury of head

2.0

18.8

221

914

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.1

18.7

546

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

18.7

1208

7423

R33

ICD-10 Finland

Retention of urine

1.3

18.6

1445

9109

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.5

18.5

612

3344

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.6

18.5

319

4262

E000001, ,

ATC

1.3

18.5

2058

13577

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

18.5

1388

8713

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.7

18.5

348

1665

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

18.5

3157

21796

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.7

18.4

105

319

N02AX02

ATC

tramadol; systemic, rectal

0.8

18.4

4359

39381

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.6

18.4

108

333

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

18.4

5785

42152

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

5.0

18.4

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.1

18.2

447

A10AB05

ATC

insulin aspart; parenteral

1.4

18.1

948

5634

H02AB06

ATC

prednisolone; systemic

0.8

18.1

5005

44658

T03

ICPC

Loss of appetite

3.1

18.1

207

SPAT1081

SPAT

Cardiorespiratory global assessment

1.4

18.0

832

4842

IHA21

NOMESCO Finland

Mini-intervention for hazardous and harmful alcohol use

5.2

18.0

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

18.0

1036

6253

Z00.0

ICD-10 Finland

General medical examination

1.2

18.0

2292

15347

Z2445

NOMESCO Finland

Psychologist

2.0

17.8

201

820

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

17.7

579

3156

A12AA04

ATC

calcium carbonate; oral

0.2

17.7

983

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.1

17.7

780

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.8

17.7

293

1353

Z11

ICPC

Compliance/being ill problem

2.7

17.6

101

308

SPAT1127

SPAT

Enema

2.2

17.6

160

602

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

17.5

596

3278

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

17.5

2132

14203

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

2.9

17.5

246

WF004

NOMESCO Finland

Palliative radiotherapy

0.4

17.4

1601

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

17.4

2980

27744

S28

ICPC

Limited function/disability (S)

2.4

17.4

127

435

A10BK03

ATC

empagliflozin; oral

0.7

17.4

691

7749

A99

ICPC

Disease/condition unspecnature/site

1.3

17.3

1277

7995

H02AA02

ATC

fludrocortisone; oral

2.2

17.3

147

538

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.9

17.3

236

1027

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

17.3

2001

19376

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

17.2

3810

26914

TK800

NOMESCO Finland

Hemodialysis

0.3

17.1

1144

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.7

17.0

520

6119

F22.0

ICD-10 Finland

Delusional disorder

2.1

17.0

173

680

R44.3

ICD-10 Finland

Hallucinations, unspecified

2.7

16.9

278

N06AX21

ATC

duloxetine; oral

1.3

16.8

1013

6158

SPAT1240

SPAT

Therapeutic discussion

1.5

16.8

580

3199

L76

ICPC

Fracture: other

1.6

16.8

447

2333

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

16.7

4078

29031

W0A10, ,

SPAT

7.5

16.6

R18

ICD-10 Finland

Ascites

0.3

16.6

1266

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

16.6

164

2566

B01AB10

ATC

tinzaparin; parenteral

0.7

16.6

684

7625

R11

ICD-10 Finland

Nausea and vomiting

1.3

16.6

1080

6641

R2110

NOMESCO Finland

Giving the first information

1.5

16.3

562

3099

Y94.0

ICD-10 Finland

Accident at home

1.8

16.2

271

1254

L01CA04

ATC

vinorelbine; systemic

0.1

16.2

510

GD1AD

NOMESCO Finland

Thorax CT examination

0.6

16.2

384

4759

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

1.9

16.2

223

974

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.3

16.1

1270

Z49.0

ICD-10 Finland

Preparatory care for dialysis

0.1

16.0

506

A04AA55

ATC

palonosetron, combinations; systemic

0.3

16.0

1037

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

15.9

611

3439

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.6

15.9

258

3500

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.4

15.9

102

1854

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

15.8

398

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.1

15.6

721

T05

ICPC

Feeding problem of adult

2.7

15.6

257

C03CA01

ATC

furosemide; systemic

1.2

15.6

6344

46930

K59.0

ICD-10 Finland

Constipation

1.4

15.6

833

4967

G72.8

ICD-10 Finland

Other specified myopathies

1.8

15.6

251

1150

B03XA02

ATC

darbepoetin alfa; parenteral

0.4

15.5

1530

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.6

15.4

361

4488

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

15.4

274

3629

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

15.4

567

3168

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

15.4

438

2321

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

15.3

3227

22651

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.4

15.2

1598

K03.66

ICD-10 Finland

Tooth plaque

1.4

15.2

744

4374

F05.8

ICD-10 Finland

Other delirium

2.1

15.2

139

525

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

4.3

15.1

TPH04, ,

SPAT

2.1

15.1

147

569

A10BJ06

ATC

semaglutide; parenteral

0.4

15.0

100

1793

N18.0

ICD-10 Finland

End-stage renal disease

0.1

15.0

726

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

14.9

133

2147

S01BC05

ATC

ketorolac; ophthalmic

1.4

14.8

668

3873

WF002

NOMESCO Finland

Radical radiotherapy

0.6

14.8

342

4262

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

14.7

1429

9266

Y94.1

ICD-10 Finland

Accident in connection with service housing

4.9

14.6

SPAT1312

SPAT

General health counselling

1.2

14.5

3426

24263

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

3.9

14.5

NF3AA

NOMESCO Finland

Femur X-ray examination

1.6

14.5

334

1687

M01AX05

ATC

glucosamine; oral

1.2

14.4

2980

20862

P19

ICPC

Drug abuse

4.1

14.4

N05AX12

ATC

aripiprazole; systemic

2.2

14.4

119

431

A05

ICPC

Feeling ill

1.5

14.4

461

2505

D07AA02

ATC

hydrocortisone; topical

1.3

14.4

1291

8285

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

14.4

1527

GD1AA, ,

SPAT

0.7

14.3

493

5672

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

4.9

14.3

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

14.2

1607

10600

SPAT1244

SPAT

Occupational therapy

2.1

14.2

140

545

P18

ICPC

Medication abuse

3.2

14.1

151

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

14.1

207

2878

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.3

14.1

1050

A10BH05

ATC

linagliptin; oral

1.3

14.0

854

5197

R03DA04

ATC

theophylline; systemic, rectal

0.7

13.9

482

5539

M01AC06

ATC

meloxicam; systemic, rectal

1.2

13.9

3827

27426

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

13.9

5037

36853

R44.1

ICD-10 Finland

Visual hallucinations

2.3

13.8

103

357

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

30.6

13.8

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.2

13.8

723

F009, G301,

ICD-10 Finland

17.7

13.7

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.8

13.7

210

949

C10AA05

ATC

atorvastatin; oral

1.1

13.7

6006

44516

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.2

13.6

2011

13638

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.4

13.6

1558

R45.1

ICD-10 Finland

Restlessness and agitation

3.7

13.5

SPAT1394

SPAT

Counselling and guidance related to living conditions

3.2

13.4

135

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

13.4

2001

18945

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.6

13.3

261

3374

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.8

13.3

1435

14042

R4120, ,

SPAT

1.9

13.3

162

681

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.5

13.3

112

OAB41, ,

SPAT

2.1

13.3

120

452

N03AX14

ATC

levetiracetam; systemic

1.6

13.3

293

1465

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

3.9

13.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

13.2

1902

12866

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

3.0

13.2

162

Z51.88

ICD-10 Finland

Other specified medical care

1.7

13.2

258

1251

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.8

13.1

216

998

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

13.1

2065

14095

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

13.0

363

1916

F0021, G308,

ICD-10 Finland

11.2

13.0

L03AA02

ATC

filgrastim; parenteral

0.5

13.0

1598

R4190

NOMESCO Finland

Nutritional therapy

0.4

12.9

1405

F0024, G301,

ICD-10 Finland

16.9

12.9

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

12.9

4098

29649

TDA90, ,

SPAT

0.7

12.9

488

5521

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.3

12.9

824

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.3

12.9

1013

T08

ICPC

Weight loss

1.7

12.9

217

1010

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

12.8

710

4259

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.2

12.8

687

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

12.8

1214

F0004, G300,

ICD-10 Finland

21.9

12.7

R45.5

ICD-10 Finland

Hostility

10.6

12.7

R63.4

ICD-10 Finland

Abnormal weight loss

1.4

12.6

527

3016

137

Kela drug reimbursment

Uraemia requiring dialysis

0.1

12.6

351

ZYC01, ,

SPAT

1.3

12.6

827

5090

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

12.6

2787

19599

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.4

12.6

645

3823

R03BB01

ATC

ipratropium bromide; inhalant

0.7

12.6

349

4183

Z08

ICPC

Social welfare problem

2.1

12.5

115

436

N80

ICPC

Head injury other

1.7

12.4

235

1130

I50.0

ICD-10 Finland

Congestive heart failure

0.8

12.4

1165

11580

N18.8

ICD-10 Finland

Other chronic renal failure

0.5

12.4

153

2229

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.7

12.4

195

WVA40, ,

SPAT

2.3

12.3

320

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.5

12.3

357

1903

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

12.2

3122

22205

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.4

12.1

491

2795

SPAT1063

SPAT

Suctioning of mucus from airways

4.0

12.0

SPAT1042

SPAT

Guidance concerning balance maintenance

2.3

12.0

309

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.7

11.9

210

990

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

11.9

572

3355

G04BD10

ATC

darifenacin; oral

2.1

11.9

108

408

S32.5

ICD-10 Finland

Fracture of pubis

1.9

11.8

160

697

-1, ,

NOMESCO Finland

1.2

11.8

2618

18400

N99

ICPC

Neurological disease other

1.9

11.8

145

612

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.5

11.8

118

1832

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

11.8

882

ZXY02

NOMESCO Finland

Neuropsychologist

3.7

11.8

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

11.7

1621

10912

Z01.8

ICD-10 Finland

Other specified special examinations

1.2

11.7

2447

17110

NG1AA, ,

SPAT

0.5

11.7

118

1826

S01.7

ICD-10 Finland

Multiple open wounds of head

2.3

11.7

313

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

11.6

897

5646

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

40.3

11.6

A69.2

ICD-10 Finland

Lyme disease

0.6

11.5

281

3458

Z75.0

ICD-10 Finland

Medical services not available in home

2.9

11.5

149

R03BB04

ATC

tiotropium bromide; inhalant

0.8

11.5

1047

10447

-1, ,

ICPC

1.5

11.5

380

2083

AA1AG, ,

SPAT

5.6

11.4

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.7

11.4

185

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

11.4

554

6012

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

15.3

11.4

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

11.3

1138

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.9

11.3

152

661

S22.3

ICD-10 Finland

Fracture of rib

1.3

11.3

826

5162

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.2

11.3

398

N02BF01

ATC

gabapentin; oral

0.7

11.2

610

6514

F009, F03,

ICD-10 Finland

4.7

11.2

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.0

11.2

138

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

0.5

11.1

1375

250, ,

Kela drug reimbursment

0.5

11.1

110

1710

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.1

11.1

299

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.2

11.0

1914

13168

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.7

11.0

310

3701

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

11.0

630

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.0

11.0

123

504

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

0.3

10.9

871

TGC00

NOMESCO Finland

Bronchial lavation

0.5

10.9

104

1638

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.3

10.9

804

5030

C10AA04

ATC

fluvastatin; oral

1.2

10.9

1418

9488

R06AE07

ATC

cetirizine; oral

1.1

10.9

4116

30075

SPAT1142

SPAT

Minor procedure on teeth, gums, mouth and pharynx

3.3

10.8

103

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

3.0

10.8

128

62670

ICD-8 Finland

Disorders of menstruation, Postmenopausal bleeding

1.8

10.8

150

660

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

10.8

907

5774

K91

ICPC

Cerebrovascular disease

1.7

10.8

215

1050

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

10.7

1125

7353

U13

ICPC

Bladder symptom/complaint other

1.5

10.7

372

2059

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.3

10.7

751

XF610, ,

SPAT

3.2

10.7

112

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.2

10.7

399

K90

ICPC

Stroke/cerebrovascular accident

1.4

10.6

465

2685

C09AA05

ATC

ramipril; oral

1.1

10.6

3986

29093

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

0.1

10.6

307

R35

ICD-10 Finland

Polyuria

1.3

10.6

905

5774

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.7

10.5

172

795

D07AC01

ATC

betamethasone; topical

1.1

10.5

4046

29578

A10BK01

ATC

dapagliflozin; oral

0.7

10.5

523

5658

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

10.5

250

1277

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

1.4

10.4

493

2886

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

10.3

3256

23482

G04BD07

ATC

tolterodine; oral

1.3

10.3

735

4581

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

2.1

10.3

384

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

10.2

603

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.2

10.2

295

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

10.2

419

4675

AA1ED

NOMESCO Finland

Trauma CT of head and neck

2.3

10.2

290

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

5.8

10.2

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

5.0

10.2

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.2

10.2

587

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.6

10.2

186

2440

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

3.8

10.2

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.4

10.0

1056

A10AE04

ATC

insulin glargine; parenteral

1.2

10.0

1155

7630

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

10.0

746

C01AA05

ATC

digoxin; systemic

0.8

9.9

1230

11885

XF606

NOMESCO Finland

Ortostatic test

1.9

9.9

128

551

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

9.9

168

2241

U29

ICPC

Urinary symptom/complaint other

1.4

9.8

392

2228

Z60.8

ICD-10 Finland

Other problems related to social environment

2.6

9.8

168

Z49.2

ICD-10 Finland

Other dialysis

0.1

9.7

269

L01CB01

ATC

etoposide; systemic

0.1

9.7

269

G04CA01

ATC

alfuzosin; oral

1.2

9.7

1716

11819

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.7

9.7

477

5164

U08

ICPC

Urinary retention

1.5

9.6

316

1731

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.4

9.6

993

HA1AA

NOMESCO Finland

X-ray mammography

0.7

9.6

428

4707

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

9.6

209

2629

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.4

9.5

213

GD1QA, ,

SPAT

2.8

9.5

138

OAB50, ,

SPAT

1.3

9.5

833

5331

Q90.9

ICD-10 Finland

Down syndrome, unspecified

88.6

9.5

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

1.8

9.5

140

629

TPH07

NOMESCO Finland

Cathetrisation of artery

0.8

9.5

1042

10192

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.6

9.4

136

1894

I67.4

ICD-10 Finland

Hypertensive encephalopathy

4.2

9.4

OAB43, ,

SPAT

0.4

9.4

1006

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.6

9.4

220

1120

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.7

9.3

342

3887

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

4.0

9.3

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

9.3

430

2510

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.3

9.3

703

4416

S82

ICPC

Naevus/mole

0.8

9.3

922

9118

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

9.3

1246

8360

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

9.3

1122

10868

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.2

9.2

1694

11699

XX2RW, ,

NOMESCO Finland

0.3

9.2

629

R44

ICPC

Respiratory, Preventive immunization/medic

1.6

9.2

223

1144

I95.9

ICD-10 Finland

Hypotension, unspecified

1.6

9.2

223

1144

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.1

9.2

4388

32455

R74

ICPC

Upper respiratory infection acute

0.8

9.2

1377

13070

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

9.2

190

2418

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.2

9.1

532

A07

ICPC

Coma

2.3

9.1

233

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

0.0

9.1

211

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.3

9.1

634

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

1.8

9.1

146

674

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

9.0

987

R51.80

ICD-10 Finland

Headache

1.2

8.9

1188

7963

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

0.4

8.9

916

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

8.9

497

R999, ,

ICD-10 Finland

3.3

8.9

AA1FD

NOMESCO Finland

Trauma CT of head and face

3.3

8.9

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

8.8

231

B05DA

ATC

Isotonic solutions

0.1

8.8

267

WX722

NOMESCO Finland

PEEP

0.7

8.8

250

2977

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.9

8.8

2898

25878

S01

ICD-10 Finland

Open wound of head

1.7

8.8

146

680

L02BA03

ATC

fulvestrant; parenteral

0.2

8.8

322

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

8.8

117

1661

SPAT1277

SPAT

Instruction concerning legal protection and patient’s rights

3.5

8.7

212

Kela drug reimbursment

Gout

0.6

8.7

131

1802

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

8.7

754

7574

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

0.3

8.7

620

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

8.7

1943

13640

S01.51

ICD-10 Finland

Open wound on lip

1.7

8.7

151

713

-31

ICPC

Medical examin/health eval partial

1.3

8.7

822

5312

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.4

8.7

972

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.8

8.7

831

8249

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

8.6

389

2262

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.2

8.6

514

S42.0

ICD-10 Finland

Fracture of clavicle

1.5

8.6

248

1324

N02CD05

ATC

eptinezumab; parenteral

+∞

8.6

H91.1

ICD-10 Finland

Presbycusis

1.2

8.6

1311

8905

P03

ICPC

Feeling depressed

1.4

8.6

437

2593

U28

ICPC

Limited function/disability (U)

1.7

8.6

160

770

B05DB

ATC

Hypertonic solutions

0.1

8.6

245

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.8

8.5

115

503

OAA80, ,

SPAT

0.1

8.5

260

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.4

8.5

372

2153

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

8.5

1228

11693

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.6

8.5

185

927

ZXD20

NOMESCO Finland

Day surgery

1.2

8.5

1229

8308

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.6

8.5

153

2008

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

2.9

8.5

107

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.6

8.4

165

2126

P01

ICPC

Feeling anxious/nervous/tense

1.4

8.4

422

2497

XW000

NOMESCO Finland

Bone marrow biopsy

0.7

8.4

268

3119

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

4.2

8.4

G47.3

ICD-10 Finland

Sleep apnoea

0.8

8.4

1363

12846

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

0.0

8.4

169

N02AA01

ATC

morphine; systemic, rectal

1.4

8.4

304

1701

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

0.3

8.4

631

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

0.7

8.3

455

4851

L02BB04

ATC

enzalutamide; oral

0.4

8.3

738

SPAT1243

SPAT

Psychiatric/psychological examination

2.0

8.3

323

U70

ICPC

Pyelonephritis/pyelitis

1.7

8.2

154

742

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

0.4

8.2

734

S20.2

ICD-10 Finland

Contusion of thorax

1.3

8.2

512

3135

C08CA01

ATC

amlodipine; oral

1.1

8.2

5841

44116

PA7BD

NOMESCO Finland

CT angiography of neck and brain

1.6

8.2

174

867

M02AA10

ATC

ketoprofen; topical

1.2

8.1

1776

12442

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

0.6

8.1

123

1685

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

0.2

8.1

338

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.3

8.1

582

SPF30

NOMESCO Finland

Relining of denture

1.5

8.0

251

1364

SPAT1058

SPAT

PEF monitoring instruction

0.8

8.0

547

5657

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

1.7

8.0

147

705

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

0.6

8.0

116

1608

WYA30, ,

SPAT

2.2

8.0

237

T11

ICPC

Dehydration

3.1

8.0

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.1

7.9

2490

17909

N43

ICPC

Neurological, Other diagnostic procedure

2.2

7.9

253

128

Kela drug reimbursment

Cancers of female genital organs

0.4

7.9

916

N02CD07, ,

ATC

19.3

7.9

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

7.9

1364

9367

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.2

7.9

1087

7310

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

0.5

7.9

1335

N02CD02

ATC

galcanezumab; parenteral

12.5

7.9

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

0.3

7.9

575

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.6

7.9

185

944

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.7

7.9

266

3063

WZA30

NOMESCO Finland

Assessment of driving capacity and statement

7.6

7.9

E66.00

ICD-10 Finland

Metabolic syndrome

0.7

7.9

205

2480

JLC30

NOMESCO Finland

Pancreatoduodenectomy

0.2

7.9

299

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.2

7.9

867

5701

D17

ICPC

Incontinence of bowel

1.7

7.8

145

697

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.8

7.8

440

4671

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

0.2

7.8

282

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

0.6

7.8

177

2206

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

7.8

403

2397

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.0

7.8

352

R02

ICPC

Shortness of breath/dyspnoea

0.8

7.8

1338

12555

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.2

7.8

442

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

0.6

7.8

140

1838

WX730

NOMESCO Finland

Conventional respirator

0.5

7.8

976

R07.4

ICD-10 Finland

Chest pain, unspecified

1.1

7.8

3564

26247

B03XA01

ATC

erythropoietin; parenteral

0.3

7.8

594

L15

ICPC

Knee symptom/complaint

0.9

7.8

2057

18661

C10AA02

ATC

lovastatin; oral

1.3

7.7

687

4406

N18

ICPC

Paralysis/weakness

1.5

7.7

256

1408

A06

ICPC

Fainting/syncope

1.6

7.7

171

861

GX1C5, ,

SPAT

0.2

7.7

295

ZXA00

NOMESCO Finland

Right side

1.1

7.7

3477

25581

L04AX01

ATC

azathioprine; systemic

0.6

7.7

142

1853

Z94.0

ICD-10 Finland

Kidney transplant status

0.2

7.7

296

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.6

7.7

120

1632

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.5

7.7

916

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.3

7.7

506

3122

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.6

7.7

119

1621

21899

ICD-8 Finland

Uterine fibroma

1.3

7.7

694

4461

D01BA02

ATC

terbinafine; oral

1.1

7.7

2659

19248

L02BG06

ATC

exemestane; oral

0.4

7.7

825

SFA10

NOMESCO Finland

One-surface restoration

1.1

7.7

4773

35754

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

0.4

7.6

650

T93

ICPC

Lipid disorder

0.8

7.6

467

4899

191

Kela drug reimbursment

Erlotinib

0.0

7.6

157

L03AA14

ATC

lipegfilgrastim; parenteral

0.4

7.6

661

F01.8

ICD-10 Finland

Other vascular dementia

2.9

7.6

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

4.0

7.6

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

0.4

7.6

753

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.1

7.6

4760

35665

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

0.6

7.6

107

1493

F0001, G300,

ICD-10 Finland

22.1

7.6

S01.2

ICD-10 Finland

Open wound of nose

1.6

7.6

161

803

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.7

7.5

214

2544

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

1.5

7.5

204

1077

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.5

7.5

1125

N05CD08

ATC

midazolam; nasal, systemic

1.4

7.5

281

1583

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.4

7.5

284

1605

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

0.5

7.4

904

F05

ICD-10 Finland

Delirium, not induced by alcohol and other psychoactive substances

4.7

7.4

N02CD01

ATC

erenumab; parenteral

4.7

7.4

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

0.3

7.4

556

SPAT1064

SPAT

Management of tracheostomy stoma

3.4

7.4

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.5

7.4

1151

H02BX01

ATC

methylprednisolone, combinations; systemic

1.3

7.4

697

4504

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

1.6

7.4

176

903

HA1AA, ,

SPAT

0.5

7.4

945

F32.0

ICD-10 Finland

Mild depressive episode

1.6

7.3

151

747

B28

ICPC

Limited function/disability (B)

2.1

7.3

267

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.5

7.3

975

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

2.5

7.3

140

B01AF02

ATC

apixaban; oral

1.1

7.3

2245

16121

163

Kela drug reimbursment

Abiraterone and enzalutamide

0.4

7.3

785

P69

ICPC

Psychological, Other reason for encounter NEC

4.4

7.3

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

1.7

7.3

116

536

A02

ICPC

Chills

2.0

7.2

323

F01.31

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism

7.2

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

2.3

7.2

195

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

0.3

7.2

498

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

0.4

7.2

782

T82

ICPC

Obesity

0.5

7.2

891

NA3BG, ,

SPAT

0.5

7.1

1010

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.1

7.1

210

C05AA08

ATC

fluocortolone; rectal, topical

1.2

7.1

1373

9523

WX900

NOMESCO Finland

Resuscitation

0.2

7.1

310

R03AC02

ATC

salbutamol; inhalant

0.9

7.1

5046

43240

D01AE15

ATC

terbinafine; topical

1.2

7.1

767

5036

SAD01, ,

SPAT

3.9

7.1

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

0.6

7.1

130

1694

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

7.1

1723

12169

G40

ICD-10 Finland

Epilepsy

2.1

7.1

255

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

0.2

7.1

265

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

5.9

7.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.9

7.0

1815

16506

WX110

NOMESCO Finland

Infiltration anesthesia

1.1

7.0

7129

54643

P71

ICPC

Organic psychosis other

6.3

7.0

SPAT1109

SPAT

Analgesia with portable analgesic pump

1.9

7.0

372

N30

ICD-10 Finland

Cystitis

1.2

7.0

746

4888

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.2

7.0

424

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

1.9

7.0

367

G04BD09

ATC

trospium; oral

1.4

7.0

330

1939

H40.9

ICD-10 Finland

Glaucoma, unspecified

1.4

6.9

280

1601

JAH00

NOMESCO Finland

Laparotomy

0.6

6.9

151

1893

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

0.7

6.9

169

2067

YX9AW, ,

NOMESCO Finland

0.1

6.9

227

SCA02

NOMESCO Finland

Preventive oral health care

1.2

6.9

685

4456

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

0.7

6.9

167

2045

E44.1

ICD-10 Finland

Mild protein-energy malnutrition

3.8

6.9

CHD00

NOMESCO Finland

Laser trabeculoplasty

1.5

6.9

189

1003

G04BD11

ATC

fesoterodine; oral

1.3

6.8

382

2304

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

0.4

6.8

568

N02CD03

ATC

fremanezumab; systemic

4.1

6.8

SPAT1232

SPAT

Communication with help of interpreter or assistant

2.7

6.8

112

ZXA05

NOMESCO Finland

Left side

1.1

6.8

3254

24004

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.5

6.7

178

936

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

0.6

6.7

151

1880

A06AC51

ATC

ispaghula, combinations; oral

1.3

6.7

502

3154

ZX090

NOMESCO Finland

Other technic of radiotherapy

0.6

6.7

131

1683

A08.3

ICD-10 Finland

Other viral enteritis

2.4

6.7

151

F0020, G309,

ICD-10 Finland

+∞

6.7

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

0.5

6.7

824

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.9

6.7

1491

13704

A10AA02, ,

ATC

0.7

6.7

170

2061

C02AC05

ATC

moxonidine; oral

0.8

6.6

370

3925

SPAT1165

SPAT

Peritoneal dialysis

2.6

6.6

123

W10

ICD-10 Finland

Fall on and from stairs and steps

1.3

6.6

531

3368

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.3

6.6

443

2745

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

0.6

6.6

137

1734

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

0.5

6.6

884

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

0.0

6.6

136

L04AX03

ATC

methotrexate; systemic

0.8

6.6

516

5237

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.2

6.6

1400

9787

R40.2

ICD-10 Finland

Coma, unspecified

1.7

6.5

109

512

F06.0

ICD-10 Finland

Organic hallucinosis

2.5

6.5

129

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.3

6.5

591

3806

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

1.3

6.5

396

2421

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

0.4

6.5

577

N06AX12

ATC

bupropion; oral

1.5

6.5

187

1003

S00.7

ICD-10 Finland

Multiple superficial injuries of head

2.3

6.5

174

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

2.3

6.5

169

A10AC01

ATC

insulin (human); parenteral

0.8

6.5

654

6450

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

0.1

6.4

196

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

1.5

6.4

183

978

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

0.4

6.4

633

F0021, G301,

ICD-10 Finland

10.7

6.4

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

0.5

6.4

1079

J43.9

ICD-10 Finland

Emphysema, unspecified

0.6

6.4

1234

180

Kela drug reimbursment

Interferon alfa

0.2

6.4

214

L01XX11

ATC

estramustine; systemic

0.2

6.4

214

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.2

6.4

644

4194

Y94.8

ICD-10 Finland

Other leisure activity accident

1.4

6.4

240

1355

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

2.8

6.4

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.6

6.4

149

1840

N03AF02

ATC

oxcarbazepine; oral

1.4

6.4

260

1490

I23.0

ICD-10 Finland

Haemopericardium as current complication following acute myocardial infarction

0.0

6.4

132

M25.5

ICD-10 Finland

Pain in joint

0.9

6.4

2234

19923

M05BA02

ATC

clodronic acid; systemic

0.2

6.4

361

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

6.4

331

1976

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

0.7

6.3

298

3242

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

0.3

6.3

399

SGB30

NOMESCO Finland

Other complicated root filling

0.7

6.3

220

2514

192

Kela drug reimbursment

Fulvestrant

0.2

6.3

243

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.6

6.3

128

633

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.8

6.3

492

4994

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.4

6.3

297

1747

VALMI, ,

NOMESCO Finland

1.1

6.3

1746

12445

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

0.3

6.3

447

J94.8

ICD-10 Finland

Other specified pleural conditions

0.6

6.2

106

1405

ZX112

NOMESCO Finland

Subcutaneous

0.6

6.2

1233

G03CB01

ATC

dienestrol; oral, vaginal

1.3

6.2

450

2817

XCW10, ,

SPAT

0.2

6.2

355

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.1

6.2

230

WPA13

NOMESCO Finland

Palliative consultation

0.3

6.2

288

5826

FHL

Lobectomy or bilobectomy

0.0

6.2

129

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

1.9

6.2

302

S01EX03, ,

ATC

1.3

6.2

357

2166

Z97.8

ICD-10 Finland

Presence of other specified devices

1.9

6.2

291

UJF32, ,

SPAT

0.6

6.2

127

1610

WX700, ,

SPAT

2.8

6.2

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

0.1

6.2

173

A10BB01

ATC

glibenclamide; oral

0.8

6.1

513

5168

S16

ICPC

Bruise/contusion

1.3

6.1

393

2421

SAA03

NOMESCO Finland

Extended examination of mouth

1.1

6.1

3116

23050

L02BG04

ATC

letrozole; oral

0.8

6.1

358

3767

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.8

6.0

418

4307

L01XE03

ATC

[U] erlotinib

0.0

6.0

125

WZC30, ,

SPAT

0.8

6.0

527

5281

L04AA06

ATC

mycophenolic acid; systemic

0.4

6.0

557

A02BC02

ATC

pantoprazole; systemic

1.1

6.0

8508

65992

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.3

6.0

395

2442

K01

ICPC

Heart pain

1.5

6.0

178

961

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021960) Folate [Moles/volume] in Serum or Plasma

6952

35580

2.12

307.65

1.9

1.8

20.19

20.15

nmol/l

0.07

5931

29742

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8836

50575

2.07

307.65

2.7

2.4

93.02

93.44

pmol/l

0.33

4812

26656

(3019309) Folate [Moles/volume] in Red Blood Cells

6237

24403

2.88

307.65

1.9

1.8

1170.02

1151.85

nmol/l

0.77

4663

17984

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

641

526

10.22

307.65

1.0

56.06

41.69

ng/l

7.05

468

325

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

641

526

10.22

307.65

1.0

568.22

729.17

ng/l

10.12

459

315

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

634

527

10.09

307.65

1.0

415.12

322.83

ng/l

6.52

467

332

(3031040) Bacteria [#/volume] in Urine by Automated count

10668

67640

2.08

293.92

6.5

6.0

2719.46

2208.41

e6/l

0.48

340

1098

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4883

24261

1.94

271.97

1.9

1.8

4648045.83

24143600.35

pmol/l

4.54

3916

19140

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12348

84688

2.33

246.27

20.6

22.5

30.47

29.43

mg/l

2.42

10980

73909

(3019550) Sodium [Moles/volume] in Serum or Plasma

12645

87747

2.46

242.80

26.1

28.1

139.81

139.38

mmol/l

48.51

12336

85848

(3023103) Potassium [Moles/volume] in Serum or Plasma

12648

87796

2.46

242.26

26.2

28.4

4.00

4.02

mmol/l

12.53

12325

85790

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12662

88135

2.45

236.67

27.6

30.7

84.62

88.13

umol/l

29.69

12380

86611

(3010813) Leukocytes [#/volume] in Blood

12674

88269

2.45

236.29

30.5

33.9

7.14

7.11

e9/l

0.46

12256

85378

(3026361) Erythrocytes [#/volume] in Blood

12671

88253

2.45

235.90

30.5

33.9

4.25

4.29

e12/l

16.87

12246

85334

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

12671

88253

2.45

235.90

30.8

34.5

38.35

38.70

9.05

12402

86688

(3007461) Platelets [#/volume] in Blood

12670

88248

2.45

235.76

30.5

34.0

234.24

237.08

e9/l

4.99

12285

85765

(3000963) Hemoglobin [Mass/volume] in Blood

12671

88260

2.45

235.70

30.7

34.2

128.07

129.21

g/l

15.03

12401

86788

(3035941) MCH [Entitic mass]

12670

88251

2.45

235.67

30.4

33.8

30.43

30.42

0.18

12405

86732

(3024731) MCV [Entitic mean volume] in Red Blood Cells

12670

88254

2.44

235.59

30.4

33.8

92.11

92.09

0.18

12405

86739

(3015377) Calcium [Moles/volume] in Serum or Plasma

6649

38051

1.76

222.43

2.6

3.4

2.35

mmol/l

0.32

5848

33777

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11517

77950

2.00

216.85

5.5

5.7

2.03

2.11

mu/l

5.16

10283

69762

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4683

24476

1.80

210.17

2.9

3.1

2.46

2.47

mmol/l

14.30

4142

21626

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7246

43017

1.73

207.55

2.3

2.4

78.18

81.26

nmol/l

14.86

6139

37229

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9093

58070

1.72

193.32

5.3

7.3

1.22

1.21

mmol/l

44.69

7634

49439

(3026008) Bacteria identified in Urine by Culture

6737

39796

1.69

190.29

4.0

3.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6316

37025

1.67

180.24

2.5

2.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

10054

66982

1.71

170.90

5.5

2.81

115.35

0.49

117

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9776

64802

1.69

167.12

4.1

4.4

15.31

15.29

pmol/l

0.25

8532

57479

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8196

51982

1.64

165.95

4.7

6.6

1.22

1.21

mmol/l

24.31

7292

47486

(3024561) Albumin [Mass/volume] in Serum or Plasma

8048

51023

1.62

160.92

3.8

4.9

34.61

34.03

g/l

17.43

7225

47134

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4176

22663

1.68

153.44

2.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

661

1795

3.06

140.21

1.2

1.3

472.55

609.35

mg/l

7.60

595

1714

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12079

86500

1.83

135.98

10.5

13.8

21.73

23.27

u/l

5.62

11431

82940

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

575

1528

3.11

126.36

1.2

1.3

5.77

28.05

e6/l

2.94

455

1163

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

578

1541

3.10

126.32

1.3

1.4

229.32

1095.03

e6/l

4.59

475

1250

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

581

1569

3.06

124.25

1.2

3.85

3.87

mmol/l

0.17

550

1462

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6967

44259

1.52

123.34

4.8

4.9

65.39

97.09

ng/l

1.29

5752

36655

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3164

17124

1.63

111.03

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

9077

61716

1.51

110.16

4.6

5.2

7.04

6.92

mmol/l

5.03

8684

59014

(3019150) Specific gravity of Urine by Refractometry

3953

22733

1.55

106.40

5.4

5.2

1.02

1.15

kg/l

0.80

2692

15723

(3035350) Ketones [Presence] in Urine by Test strip

7811

51781

1.48

104.81

4.8

1.85

3.24

estimate

0.48

1587

11893

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

9205

63305

1.48

100.28

28.3

30.5

329.79

329.87

g/l

0.34

9086

62748

(3009466) Valproate [Moles/volume] in Serum or Plasma

409

1035

3.24

97.22

3.2

3.8

304.64

324.60

umol/l

1.95

333

864

(3018418) pH of Serum or Plasma

5627

35366

1.46

96.26

2.9

4.3

7.40

3.69

4209

25816

(3009261) Glucose [Presence] in Urine by Test strip

7793

52146

1.45

95.41

4.8

0.21

0.38

estimate

0.27

1487

11162

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2906

15900

1.59

95.40

1.9

—

(3023368) Bacteria identified in Blood by Culture

5768

36522

1.46

94.33

3.8

4.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

7645

51090

1.44

93.28

4.8

0.00

estimate

0.06

1495

11426

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10369

73672

1.49

89.77

5.8

8.6

80.18

84.68

u/l

12.52

9560

69361

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11215

81219

1.53

86.01

5.3

6.1

6.16

6.15

mmol/l

0.08

9728

71703

(3015736) pH of Urine

6370

41565

1.42

85.61

4.3

4.2

6.33

6.34

0.12

3414

21785

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5538

35342

1.43

83.56

2.3

2.2

275.01

222.65

u/l

3.20

5176

33076

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5820

37515

1.42

82.81

5.1

5.0

1.02

0.90

estimate

0.07

1238

9267

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5175

33141

1.40

73.74

2.4

2.5

2.90

3.07

mg/l

5.05

4282

28346

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

9546

67958

1.40

70.03

4.0

4.8

15.00

16.19

mm/h

9.34

8540

62239

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3017

32135

0.69

66.60

1.7

1.9

1.21

1.25

mmol/l

2.80

2472

25733

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

271

684

3.23

64.70

2.2

2.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10887

79704

1.42

64.25

7.0

7.9

41.28

40.98

mmol/mol

2.40

9615

72200

(3029937) Albumin [Presence] in Urine by Test strip

4656

30061

1.37

59.59

5.0

4.9

0.00

estimate

1.84

1301

10031

(3032080) INR in Blood by Coagulation assay

8043

56443

1.34

58.74

20.2

22.1

1.42

1.41

inr

0.33

7028

47946

(3023410) Appearance of Cerebral spinal fluid

241

635

3.09

53.68

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

131

227

4.68

52.42

1.7

2.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

131

230

4.62

51.63

1.7

2.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

9031

65346

1.31

47.36

25.6

28.2

14.00

14.13

17.02

8916

64384

(4035726) Immunohistochemistry procedure

691

9457

0.57

45.02

1.3

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10893

81338

1.33

42.47

5.4

6.5

2.40

mmol/l

0.20

9529

72799

(40768804) Tissue Pathology biopsy report

3834

37138

0.77

39.46

2.3

2.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

10613

79263

1.31

38.73

20.6

23.0

66.90

67.28

ml/min/173m2

1.34

9972

74644

(3012516) Albumin [Mass/volume] in Urine

3769

36503

0.77

38.44

2.9

3.5

49.29

53.83

mg/l

0.36

2450

23724

(3041096) Erythrocytes [Presence] in Urine by Automated

3845

25354

1.30

38.43

4.3

4.4

0.73

0.43

estimate

0.35

1148

8794

(3009508) Creatinine [Moles/volume] in Urine

3806

36665

0.77

36.72

2.8

3.4

6.92

6.61

mmol/l

5.11

3027

29938

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1117

13005

0.66

35.79

1.2

1.3

15.87

15.30

u/ml

0.07

324

4197

(3037522) Nuclear Ab [Titer] in Serum

871

10649

0.64

35.24

1.2

1.3

494.57

503.46

titre

0.06

184

2618

(3019225) pH of Specimen

1904

11491

1.38

34.08

3.9

4.7

7.36

0.65

1248

8113

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2089

12851

1.36

33.11

9.6

9.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1235

13839

0.69

32.00

1.2

1.3

45.17

43.16

iu/ml

0.13

381

4130

(3020682) Albumin/Creatinine [Ratio] in Urine

3982

37593

0.79

30.75

3.5

4.2

7.54

10.08

mg/mmol

2.73

2471

23540

(3006270) Folate [Moles/volume] in Blood

258

956

2.19

29.07

1.3

1.2

330.62

304.89

nmol/l

1.02

203

700

(3044889) 12 lead EKG panel

8567

63246

1.23

28.64

5.0

5.2

0.56

683.32

0.50

148

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6833

49370

1.22

27.95

3.0

3.3

48.86

59.15

u/l

16.01

6053

44480

(3011397) Hemoglobin [Presence] in Urine by Test strip

3673

24860

1.25

27.87

4.7

4.5

0.33

0.29

0.08

396

(3014271) Vancomycin [Susceptibility]

241

891

2.20

27.33

3.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3475

23490

1.25

26.38

4.6

4.7

195.44

413.83

ng/l

4.85

3169

21170

(3020779) Urea [Moles/volume] in Serum or Plasma

1101

12108

0.71

25.11

2.9

6.0

11.16

12.21

mmol/l

4.45

1005

11356

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10421

79019

1.23

24.23

4.6

5.5

4.29

4.28

mmol/l

0.17

9096

70874

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

817

4487

1.49

24.12

1.2

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

209

772

2.20

23.82

1.1

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

381

1751

1.77

23.19

1.1

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

543

6653

0.64

21.74

2.7

2.8

10.90

10.79

g/l

0.18

457

6064

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1825

11703

1.29

20.83

2.5

2.6

5.03

6.29

ug/l

3.76

1340

9935

(3028026) IgM [Mass/volume] in Serum or Plasma

410

5298

0.61

20.77

2.0

1.9

2.19

1.39

g/l

1.91

327

4723

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1336

13856

0.75

20.47

2.8

3.9

10.67

24.29

ug/l

3.32

1087

11675

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4643

33009

1.20

20.20

2.3

2.6

192.61

64.66

u/l

0.47

4255

30296

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

641

7460

0.68

19.85

1.4

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

880

5092

1.42

19.72

1.9

2.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

227

3331

0.54

18.61

1.6

9.38

7.99

iu/ml

0.22

777

(3018095) Leukocytes [#/volume] in Urine

5648

41057

1.18

18.48

4.4

4.5

148.14

144.67

e6/l

0.08

4112

30329

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10246

78229

1.19

18.38

4.5

5.4

1.46

1.44

mmol/l

4.04

8870

69537

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

820

4745

1.41

18.37

1.9

—

(3017181) Myelocytes/Leukocytes in Blood

885

9606

0.72

18.30

3.1

4.0

0.81

0.95

0.58

255

3222

(3002256) Pathology report gross observation

1344

13721

0.77

18.16

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

849

4958

1.40

18.04

1.5

1.64

1.65

0.12

678

3945

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

204

3060

0.53

18.02

1.4

1.5

—

(3000492) Spirometry study

552

6488

0.67

17.97

1.5

1.6

—

(3002179) Metamyelocytes/Leukocytes in Blood

825

9029

0.72

17.95

3.0

3.9

0.77

0.69

0.33

229

3019

(3021440) Promyelocytes/Leukocytes in Blood

845

9176

0.72

17.49

3.1

4.0

0.09

0.10

0.15

218

2816

(3003694) ABO and Rh group [Type] in Blood

2333

22226

0.81

17.22

1.2

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9850

75119

1.18

17.03

3.9

4.6

1.19

1.23

mmol/l

10.01

8388

65740

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5759

42121

1.17

16.96

2.8

3.3

135.24

157.96

ug/l

10.86

5038

37948

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1684

16583

0.79

16.85

2.6

5.2

1.00

1.05

mmol/l

9.56

1470

15120

(3026493) Urate [Moles/volume] in Serum or Plasma

2888

26894

0.83

16.79

2.4

3.1

352.73

366.95

umol/l

8.82

2292

22670

(3009445) Proteinase 3 Ab [Units/volume] in Serum

382

4771

0.63

16.67

1.4

1.5

35.64

19.65

iu/ml

—

102

(3014051) Protein [Presence] in Urine by Test strip

3601

25382

1.19

16.50

3.5

3.7

0.14

0.09

0.70

169

1077

(3025159) Blasts/Leukocytes in Blood

844

9082

0.73

16.44

3.2

4.1

0.76

0.32

0.48

211

2611

(3002582) Erythrocytes [#/volume] in Urine

5228

38041

1.17

16.21

3.8

81.98

108.88

e6/l

0.74

4073

29785

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

370

4621

0.63

16.15

2.0

3.0

577.52

2924.42

u/ml

1.97

294

3944

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

634

7104

0.70

15.85

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5042

36662

1.17

15.59

5.5

6.6

3.97

5.12

ug/l

1.57

4340

32321

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

648

7214

0.71

15.58

1.2

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1627

15918

0.80

15.21

2.7

3.9

244.19

251.56

u/l

1.01

1452

14924

(3051387) C reactive protein [Mass/volume] in Capillary blood

441

2370

1.51

14.52

3.7

4.0

29.94

30.68

mg/l

0.15

338

1748

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

245

3277

0.59

14.34

1.7

1.5

20.50

16.42

iu/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

187

2676

0.56

14.13

1.8

2.9

155.73

1174.32

u/ml

2.65

161

2420

(3022145) Colonoscopy Study observation

1039

10616

0.77

13.91

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

142

2190

0.52

13.81

1.2

—

3.55

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

147

2242

0.52

13.80

1.2

1.3

3.63

4.62

u/ml

0.49

362

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

147

2239

0.52

13.74

1.2

6.54

4.57

u/ml

0.33

238

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

158

2347

0.54

13.60

1.2

60.24

42.92

u/ml

—

114

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

123

1976

0.50

13.59

1.2

3.02

5.84

u/ml

—

141

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

330

4057

0.65

13.42

2.3

4.2

154.70

104.06

u/ml

0.46

304

3890

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1491

9815

1.25

13.38

2.8

4.1

1.23

mmol/l

4.83

1209

8391

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

177

2531

0.56

13.36

1.4

0.23

g/l

0.15

164

2375

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

183

2586

0.56

13.24

1.4

1.5

1.15

1.16

g/l

0.06

170

2439

(3007164) IgA [Mass/volume] in Serum or Plasma

1524

14806

0.81

13.20

1.5

2.86

2.75

g/l

0.54

734

7975

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

154

2252

0.55

12.60

1.6

2.2

204.62

218.00

1.02

138

2123

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

297

3676

0.64

12.49

1.4

1.6

36.83

38.49

u/l

0.69

234

3057

(3020191) Ethanol [Moles/volume] in Serum or Plasma

115

439

2.12

12.32

1.2

0.82

0.93

promille

0.37

335

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

336

4039

0.66

12.28

1.2

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

193

2633

0.58

12.26

1.6

2.0

3.57

3.67

g/l

0.53

182

2490

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

1712

0.49

12.18

2.5

3.6

261.50

2158.52

iu/ml

1.11

248

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

168

2368

0.57

12.08

1.5

1.9

91.71

88.11

1.57

154

2273

(3017143) Hepatitis C virus Ab [Presence] in Serum

583

6323

0.73

11.90

1.2

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1775

12042

1.21

11.89

3.3

231.00

282.36

ng/l

5.90

1646

11147

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

747

4598

1.32

11.39

1.8

2.1

856.47

593.94

ug/l

0.44

696

4382

(3045142) Bone marrow Pathology biopsy report

1366

0.45

11.36

1.1

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

539

5873

0.73

11.34

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

231

2956

0.62

11.32

1.2

0.36

1.03

u/ml

2.28

277

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

434

4885

0.71

11.15

2.8

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

336

3952

0.68

11.02

1.2

1.3

291.51

262.54

u/ml

0.29

303

3596

(36304419) Bacteria [Presence] in Urine

4209

30791

1.14

10.92

3.6

3.7

0.65

450.76

estimate

1.12

213

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1258

8325

1.24

10.71

4.4

6.2

24.37

24.49

mmol/l

0.53

1205

7963

(3007566) Smooth muscle Ab [Titer] in Serum

144

2040

0.56

10.60

1.1

91.25

152.86

titre

1.42

147

(3047181) Lactate [Moles/volume] in Blood

599

3608

1.35

10.59

4.0

5.3

1.38

1.35

mmol/l

0.19

537

3206

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

894

0.35

10.59

1.3

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

123

513

1.94

10.43

1.0

1.1

—

(3039000) Anion gap in Blood by calculation

434

2485

1.42

10.43

4.2

6.0

11.33

11.38

mmol/l

0.10

396

2224

(3018572) Chloride [Moles/volume] in Blood

434

2485

1.42

10.43

4.2

6.0

105.12

104.74

mmol/l

0.83

396

2225

(3022621) pH of Urine by Test strip

1238

8211

1.23

10.31

3.4

6.13

6.06

2.29

959

5971

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

237

2938

0.64

10.11

1.9

2.5

1.57

1.90

mg/l

10.62

176

2549

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1336

0.48

10.04

1.4

1.9

601.33

2342.93

u/ml

—

(3003434) Protein [Mass/volume] in Pleural fluid

204

2610

0.62

10.04

1.4

1.5

29.65

30.81

g/l

0.74

181

2338

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1540

0.51

10.03

1.1

1.2

50.69

48.77

u/ml

—

166

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1443

9751

1.21

10.00

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

298

1601

1.51

9.97

7.0

12.7

8.32

7.38

mmol/l

1.19

244

1318

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4007

29370

1.14

9.88

4.9

5.4

21.81

22.72

3.44

2105

16747

(3021879) Hepatitis B virus core Ab [Presence] in Serum

370

4190

0.70

9.88

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1351

0.50

9.46

1.7

1.8

2.88

3.14

mmol/l

1.15

992

(4024509) Urine culture

843

5406

1.27

9.45

2.0

2.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

787

7934

0.79

9.38

5.0

7.4

24.19

24.27

mmol/l

0.25

748

7654

(40768797) Stomach Pathology biopsy report

1441

13641

0.83

9.36

1.2

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

183

2349

0.62

9.17

1.6

1.7

12.41

13.15

mg/l

0.52

159

2128

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7249

55184

1.12

9.17

4.0

6.3

12.42

12.72

umol/l

1.04

6717

52482

(3036489) Thrombin time

286

3340

0.68

9.09

1.5

1.8

21.09

21.87

0.84

258

3062

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

195

2459

0.63

9.04

1.5

23.76

7.96

iu/ml

0.29

600

(3023199) Leukocytes [#/volume] in Pleural fluid

175

2257

0.62

8.96

1.4

1.5

3311.87

2649.66

e6/l

0.20

134

1582

(3023419) Bacteria identified in Sputum by Culture

114

1639

0.56

8.92

2.0

2.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5790

43589

1.12

8.84

3.1

3.6

1988.65

2106.89

ng/l

1.04

4954

38595

(3000850) Epithelial cells [#/volume] in Urine

3694

27094

1.13

8.82

2.9

5.87

5.07

e6/l

3.66

3376

24638

(40768795) Lymph node Pathology biopsy report

1018

0.46

8.44

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

102

1485

0.55

8.38

1.5

1.4

218.87

298.48

pmol/l

0.61

1434

(40768806) Pleura Pathology biopsy report

146

1932

0.60

8.36

1.4

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

181

2272

0.64

8.26

1.3

1.4

—

(3045788) Cell count panel - Pleural fluid

134

1804

0.59

8.23

1.4

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

192

2376

0.65

8.20

1.2

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

385

4196

0.73

8.18

1.9

2.3

0.00

g/l

0.28

324

3624

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

700

7032

0.79

8.11

1.3

—

(40768441) Liver Pathology biopsy report

595

0.31

8.08

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

485

5096

0.76

8.02

2.2

2.6

0.37

0.35

iu/ml

0.38

271

2821

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1199

0.51

7.93

1.2

—

(40768793) Breast Pathology biopsy report

160

2044

0.63

7.92

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

151

1953

0.62

7.88

1.7

2.0

2.84

3.19

ratio

5.12

127

1584

(40768443) Skin Pathology biopsy report

474

4964

0.76

7.66

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

280

1571

1.44

7.64

1.0

1.1

8.30

15.71

eliau/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

160

2027

0.63

7.64

1.4

1.5

50847.58

62520.97

e6/l

0.29

107

1137

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1001

0.49

7.40

1.1

1.2

43.60

35.56

u/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

409

4346

0.75

7.36

1.9

2.3

0.02

0.04

g/l

1.35

346

3847

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

122

1630

0.60

7.32

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

333

1.96

7.30

2.5

2.2

57.07

53.62

umol/l

0.41

276

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

825

8039

0.81

7.23

2.5

3.0

58.38

55.60

ml/min/173m2

1.94

346

3861

(4281824) Cell count and differential, peritoneal fluid

1030

0.51

7.12

1.1

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1987

17971

0.87

7.12

3.6

4.8

—

(3052592) Norovirus Ag [Presence] in Stool

271

2.05

7.06

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

993

0.50

7.02

1.0

1.1

1.60

1.59

g/l

0.11

885

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

186

2236

0.66

6.97

1.3

1.2

157.14

246.34

titre

0.95

172

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

367

3927

0.75

6.95

1.9

2.4

0.00

g/l

-0.00

321

3615

(46235355) HIV 1 and 2 tests - Meaningful Use set

772

7528

0.82

6.82

1.2

1.5

—

(40768800) Prostate Pathology biopsy report

221

2559

0.69

6.81

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

167

864

1.56

6.79

1.3

—

(3036603) Volume of Urine

761

0.44

6.76

1.4

1.5

1765.50

1752.05

0.04

728

(3020876) Protein [Mass/time] in 24 hour Urine

134

1710

0.63

6.67

1.6

2.3

0.78

1.00

g/24h

0.54

960

(4034850) Laboratory test

463

2881

1.30

6.67

14.1

14.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1328

0.58

6.65

1.1

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

180

2154

0.67

6.62

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

132

1675

0.63

6.43

1.2

1.4

6.50

6.40

mmol/l

0.17

112

1583

(3024980) IgG subclass 4 [Mass/volume] in Serum

1231

0.57

6.37

1.7

1.5

0.69

0.89

g/l

1.23

952

(3000991) Gas panel - Venous blood

1213

11276

0.85

6.29

4.1

7.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1091

0.55

6.26

1.1

—

108.97

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1010

0.54

6.11

1.1

1.2

256.39

283.68

u/ml

0.34

577

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1276

0.59

6.09

1.2

—

17.51

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

143

1760

0.65

6.08

1.3

334.36

446.06

u/l

0.99

130

1663

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1111

0.56

6.06

1.3

1.2

158.94

161.52

au/ml

0.08

328

(40768446) Kidney Pathology biopsy report

237

0.20

6.01

1.0

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1326

12199

0.86

6.00

2.3

2.6

65.49

65.61

g/l

0.21

1095

10893

(3030467) Casts [#/volume] in Urine by Automated count

4401

33146

1.10

5.99

3.6

3.7

0.56

0.51

e6/l

0.52

3358

25295

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

178

2083

0.68

5.88

1.2

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

100

1322

0.61

5.85

1.3

0.12

0.24

nmol/l

—

(40757373) Influenza virus identified in Isolate

236

2.02

5.83

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

458

2903

1.28

5.78

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

458

2903

1.28

5.78

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

193

2216

0.70

5.75

1.2

1.3

30.88

38.48

u/l

0.65

164

1898

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2611

19184

1.12

5.73

3.4

3.5

2.75

2.64

e6/l

0.20

1331

10018

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1299

0.61

5.63

1.3

19.53

0.71

nmol/l

0.49

1236

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1167

0.59

5.61

1.3

0.20

nmol/l

0.22

951

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

114

1444

0.63

5.57

3.2

3.5

—

(3021589) Normoblasts [#/volume] in Blood

4780

40737

0.92

5.54

11.3

13.5

0.00

e9/l

0.23

3896

32777

(3004809) Band form neutrophils/Leukocytes in Blood

191

2181

0.70

5.53

3.4

3.6

1.72

1.53

0.25

149

1900

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3010

26213

0.90

5.53

2.2

2.6

—

(1761868) Lipid panel - Serum or Plasma

2363

20837

0.89

5.49

3.6

4.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1290

0.61

5.48

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

1148

0.59

5.45

1.2

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

204

2.05

5.43

1.7

1.8

1.19

mmol/l

0.18

198

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2184

19330

0.89

5.42

1.9

2.7

0.82

0.81

mmol/l

0.26

1915

17838

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

330

3451

0.76

5.39

1.6

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

120

1491

0.64

5.39

1.7

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

159

1866

0.68

5.37

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2805

20755

1.11

5.37

3.3

3.4

1.53

1.35

e6/l

0.56

1522

11647

(21494434) Karyotype in Bone marrow

1162

0.60

5.35

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1786

15981

0.88

5.33

1.8

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

828

5648

1.19

5.24

3.6

4.7

0.91

0.85

3.45

786

5358

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

416

1.71

5.22

2.0

2.4

9.55

10.04

kpa

1.08

416

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

416

1.71

5.22

2.0

2.4

4.86

4.95

kpa

0.32

416

(3008898) HLA-B27 [Presence]

1234

0.62

5.21

1.0

—

(21494755) Public health laboratory ask at order entry panel

655

0.48

5.20

1.3

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

894

6146

1.18

5.18

3.5

4.5

1.62

1.51

1.52

852

5851

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

633

6107

0.83

5.07

1.9

2.3

3.71

3.72

g/l

0.07

506

5428

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

603

0.47

5.03

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

679

0.50

5.03

1.0

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

568

0.45

5.00

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1101

0.60

4.99

1.9

2.1

521.48

784.63

1.63

1086

(3034860) Kappa light chains.free [Mass/volume] in Serum

557

5425

0.82

4.93

2.5

3.1

57.14

79.70

mg/l

1.05

468

4581

(40759836) Histone Ab [Presence] in Serum by Immunoblot

587

0.46

4.93

1.0

1.1

—

(3016228) CD19 cells/cells in Blood

342

0.31

4.89

3.5

1.7

4.92

7.51

0.91

326

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

637

6119

0.83

4.89

1.9

2.3

4.10

4.16

g/l

1.13

508

5442

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

122

1476

0.66

4.86

3.1

3.7

27.51

50.31

u/ml

3.12

114

1430

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

638

6123

0.83

4.85

1.9

2.3

7.61

7.53

g/l

0.50

509

5439

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

118

613

1.55

4.85

1.1

1.2

1.97

2.36

mmol/l

5.20

108

550

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

557

5413

0.82

4.83

2.5

3.1

53.76

52.47

mg/l

0.04

470

4571

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

163

907

1.45

4.82

1.2

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

571

0.46

4.82

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

570

0.46

4.80

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

295

1.80

4.77

3.2

2.8

29.13

28.90

umol/l

0.06

224

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

165

923

1.44

4.76

1.2

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

846

7910

0.85

4.75

3.9

6.5

24.67

24.78

mmol/l

0.34

835

7830

(21494814) CD8 cells/Lymphocytes in Specimen

333

0.31

4.67

3.5

1.7

28.23

32.07

0.60

333

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

115

1393

0.66

4.63

1.3

24.04

13.23

u/l

1.22

1275

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

263

1.84

4.63

1.5

1.4

17.03

16.67

pmol/l

0.19

207

(3011412) CD3 cells [#/volume] in Blood

712

0.53

4.63

2.3

1.8

910.88

1032.94

e6/l

0.57

652

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

561

0.47

4.61

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

550

0.47

4.61

1.0

1.1

—

(3027945) Reticulocytes/Erythrocytes in Blood

2327

17181

1.11

4.60

1.9

2.3

1.73

1.78

1.47

1907

15039

(3033658) Prothrombin time (PT) actual/Normal

3009

25996

0.91

4.56

3.4

4.3

79.81

80.97

1.72

2934

25483

(3018333) Ribosomal P Ab [Presence] in Serum

543

0.47

4.46

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

160

1807

0.71

4.43

1.2

1.4

—

(3042631) Mycobacterium sp identified in Specimen

170

1899

0.72

4.41

2.4

2.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

540

0.48

4.40

2.5

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

364

1.68

4.37

1.4

82.57

84.95

umol/l

0.06

210

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1181

0.64

4.36

1.0

1.2

53.90

62.54

u/l

1.40

1028

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

199

2164

0.74

4.36

1.2

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

494

0.45

4.36

1.9

1.3

0.78

1.67

u/ml

0.77

300

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

544

5238

0.83

4.32

1.9

2.4

1.40

1.12

g/l

0.63

414

4364

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

961

0.61

4.32

1.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

961

0.61

4.32

1.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

961

0.61

4.32

1.2

1.5

—

(4268621) Lupus anticoagulant assay

579

0.50

4.31

2.1

2.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

366

0.37

4.30

1.0

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

756

0.56

4.28

3.5

3.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1648

11991

1.12

4.26

4.2

4.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

690

0.55

4.20

1.1

1.2

252.50

132.81

titre

—

121

(3035715) Granulocytes [#/volume] in Blood

153

1721

0.71

4.17

2.3

3.1

4.87

4.53

e9/l

0.72

153

1716

(3026782) Osmolality of Urine

3184

23960

1.09

4.17

3.1

3.3

539.98

525.12

mosm/kgh2o

4.04

2791

21014

(3048689) Calprotectin [Mass/mass] in Stool

991

9052

0.87

4.08

1.8

1.9

181.84

177.19

ug/g

0.12

713

6966

(4062490) Immunoglobulin typing, IgG

747

0.58

3.93

1.5

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5487

46064

0.93

3.91

2.6

3.0

—

estimate

—

(1002224) Polysomnography panel

121

1400

0.69

3.90

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

756

0.58

3.90

1.4

0.36

0.47

g/l

1.61

550

(3028192) IgG subclass 2 [Mass/volume] in Serum

756

0.58

3.90

1.4

2.62

2.89

g/l

0.68

552

(3027135) IgG subclass 1 [Mass/volume] in Serum

756

0.58

3.90

1.4

6.76

7.14

g/l

0.33

545

(3033099) Centromere Ab [Titer] in Serum

209

0.31

3.88

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

416

0.44

3.87

1.3

1.8

8718.00

4422.51

e6/l

0.22

273

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

566

5370

0.84

3.84

1.9

2.3

10.48

10.28

g/l

0.40

428

4615

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

840

0.61

3.79

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

521

0.51

3.78

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

387

2539

1.23

3.77

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1005

0.65

3.75

1.2

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

601

5660

0.85

3.75

1.9

2.3

2.93

2.97

g/l

0.47

472

4976

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

747

0.59

3.75

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

430

0.47

3.69

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

387

2546

1.23

3.68

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

292

0.36

3.66

1.1

1.6

191.69

188.07

0.05

266

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

170

1838

0.74

3.65

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1057

0.66

3.65

1.1

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

868

0.63

3.60

1.1

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1072

0.67

3.59

2.3

4.0

47.68

68.96

u/ml

0.49

1043

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

381

2511

1.23

3.57

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

346

0.42

3.56

3.0

2.2

0.62

mmol/l

0.04

346

(3008116) Ketones [Moles/volume] in Urine by Test strip

221

1.79

3.54

1.3

1.4

0.21

0.29

mmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

4093

34618

0.93

3.51

2.3

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

166

1788

0.74

3.50

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

239

2450

0.78

3.48

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

419

0.48

3.46

1.1

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

419

0.48

3.46

1.1

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

291

2912

0.80

3.45

1.6

41.00

34.07

u/ml

0.36

426

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

118

1337

0.71

3.43

1.1

—

1.06

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

964

0.66

3.41

1.3

1.7

4.24

4.93

mg/l

1.04

909

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

517

4886

0.85

3.39

2.4

3.0

3.84

7.42

ratio

0.75

360

2934

(3017446) Testosterone [Moles/volume] in Serum or Plasma

593

5541

0.85

3.38

2.0

2.1

10.61

10.98

nmol/l

0.41

486

4646

(40765096) Chromosome analysis panel by Banding

349

0.44

3.38

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

137

794

1.39

3.37

1.7

1.8

8.50

8.13

mmol/l

0.46

137

794

(3008536) Aspergillus sp Ab [Presence] in Serum

196

0.33

3.34

1.3

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

189

1155

1.32

3.32

1.6

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

368

0.46

3.30

1.4

1.6

15451.82

18633.40

e6/l

0.11

200

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1004

0.67

3.29

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

296

2939

0.81

3.29

1.3

1.4

—

(3003181) Sodium [Moles/volume] in Urine

409

2742

1.21

3.27

1.3

1.4

62.59

59.74

mmol/l

0.81

331

2233

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1088

0.69

3.26

1.3

—

nmol/l

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

576

0.57

3.23

1.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

576

0.57

3.23

1.2

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

576

0.57

3.23

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

717

0.62

3.23

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

717

0.62

3.23

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

844

0.65

3.21

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

872

0.65

3.19

1.1

1.2

11.04

4.38

u/ml

0.66

297

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

109

1229

0.71

3.12

1.3

1.4

15.10

13.61

u/l

1.41

104

1173

(3011985) Renin [Units/volume] in Plasma

110

1237

0.71

3.10

1.2

1.3

31.68

59.09

mu/l

2.09

1078

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

423

0.51

3.09

1.3

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

175

0.32

3.09

21.7

31.3

5.20

6.70

ug/l

—

142

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

444

0.52

3.09

2.2

2.5

41.19

36.13

0.63

264

(4027681) Cerebrospinal fluid IgG ratio and IgG index

225

1.72

3.09

1.2

0.49

0.52

ratio

0.46

141

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

765

0.64

3.04

1.2

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

399

3814

0.84

3.03

1.1

1.17

1.22

u/ml

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

116

2.01

3.02

1.2

20.75

50.67

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

144

1544

0.75

3.00

1.3

1.4

—

(3003129) Base excess in Capillary blood by calculation

126

1376

0.73

2.97

1.8

2.5

0.89

0.52

mmol/l

0.49

108

1320

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

741

0.64

2.97

1.2

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

731

0.64

2.97

1.1

117.22

113.89

0.51

623

(3004716) Salmonella sp identified in Stool by Organism specific culture

418

2837

1.19

2.96

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

118

1.98

2.90

2.1

2.4

138.13

127.62

nmol/l

0.28

102

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

955

8542

0.89

2.88

4.7

7.6

1.42

1.29

3.24

950

8473

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

840

0.67

2.85

1.1

1.2

4.91

4.67

u/ml

0.05

371

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

574

0.60

2.83

1.2

1.5

—

(3017354) Segmented neutrophils/Leukocytes in Blood

130

1401

0.74

2.83

2.7

3.6

57.45

59.37

0.40

1166

(3021162) Amylase [Enzymatic activity/volume] in Specimen

166

0.34

2.83

2.4

2.6

1034.43

1285.77

u/l

—

157

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

416

1.49

2.81

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

266

0.42

2.77

1.4

1.3

36.20

35.87

u/l

—

216

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

118

1285

0.74

2.76

1.1

1.2

—

9.74

u/ml

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

303

2941

0.83

2.75

1.3

1.4

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

568

0.61

2.73

1.3

1.5

3.41

2.38

0.39

472

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

211

2124

0.80

2.72

1.2

1.4

—

(3025130) Human papilloma virus identified in Specimen

456

0.56

2.72

2.0

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

308

0.47

2.72

1.2

1.3

1.54

1.52

g/l

0.11

308

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

140

0.29

2.70

1.4

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

927

8273

0.89

2.70

4.8

7.8

0.70

0.63

6.35

919

8209

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

400

3780

0.85

2.70

1.1

67.01

119.89

u/ml

4.05

143

1201

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

254

1661

1.23

2.67

2.2

32.60

26.92

mg/l

0.68

570

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

643

0.64

2.66

2.3

2.2

15.33

91.92

ug/min

—

159

(3027456) Digoxin [Moles/volume] in Serum or Plasma

600

4235

1.15

2.62

3.9

3.4

0.77

0.82

nmol/l

2.23

485

3439

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

152

1.80

2.61

3.9

2.9

0.65

0.47

u/field

0.48

152

(3005532) Lymphocytes/Leukocytes in Pleural fluid

648

0.64

2.58

1.2

1.5

56.43

68.53

1.40

526

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

158

0.36

2.56

2.1

4.2

48.86

51.82

u/l

—

151

(3044007) Cell count panel - Peritoneal fluid

352

0.52

2.51

1.7

1.6

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

2.46

2.51

1.5

1.2

45.38

42.74

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

424

0.57

2.50

1.9

2.2

8.28

30.42

iu/ml

—

(44813793) Dust mix specific IgE antibody measurement

413

0.56

2.49

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

151

1562

0.78

2.48

1.2

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

307

0.50

2.46

1.2

1.4

14.04

15.24

g/l

0.22

234

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

2.46

0.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

973

0.72

2.46

2.0

2.2

622.00

651.74

0.29

609

(3000494) Fungus identified in Specimen by Culture

1236

10814

0.91

2.45

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

439

0.59

2.40

1.9

1.4

5.53

6.04

u/l

0.40

357

(3035880) pH of Pleural fluid

959

0.72

2.39

1.2

1.3

7.40

7.41

0.31

670

(3037692) Legionella sp identified in Specimen by Organism specific culture

364

0.55

2.34

1.0

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

592

0.65

2.31

4.4

5.2

97.92

128.47

u/ml

—

182

(3028626) Oxygen [Partial pressure] in Capillary blood

371

3476

0.85

2.30

2.3

3.1

7.54

7.73

kpa

1.57

360

3387

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

678

0.68

2.29

1.1

1.2

91.31

100.16

u/l

0.26

568

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

196

1.64

2.27

1.1

—

(3017732) Neutrophils [#/volume] in Blood

1297

11278

0.92

2.26

2.9

3.2

5.59

5.08

e9/l

0.80

974

9152

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

2.26

0.0

3.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

492

1.39

2.23

1.2

1.3

1.30

1.14

nmol/l

0.43

352

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

108

1149

0.75

2.23

1.1

1.2

257.22

262.57

pmol/l

0.09

932

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

468

0.62

2.21

1.0

300.55

293.94

mg/l

0.19

415

(3012565) Volume of 24 hour Urine

486

0.63

2.17

1.7

2.2

1761.48

1779.66

0.04

403

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

816

7238

0.90

2.17

1.5

1.7

1.58

1.57

g/l

0.17

629

6183

(3047189) Immunofixation for 24 hour Urine

660

0.68

2.17

1.1

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

660

0.68

2.17

1.1

1.2

34.14

30.82

u/l

0.17

542

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

206

0.43

2.17

1.3

1.2

0.49

0.62

ratio

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

110

1161

0.76

2.16

1.0

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

2.68

2.14

1.5

1.2

2.33

2.05

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

167

1672

0.80

2.14

4.9

5.7

13.50

12.81

mg/l

1.04

148

1509

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

356

1.45

2.11

1.1

38.77

48.98

mg/l

1.33

308

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

2.10

0.0

12.9

—

208.68

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

277

0.52

2.06

1.1

1.3

—

(3000012) Reticulocyte production index

244

2342

0.84

2.06

1.8

2.1

0.88

0.03

154

1675

(1616796) Gas panel - Central venous blood

330

3088

0.86

2.05

2.5

3.9

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

285

0.54

2.01

1.4

1.5

23.57

9.08

—

144

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

101

613

1.33

2.01

2.5

2.0

2.48

2.43

u/field

0.03

407

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

210

0.46

2.00

1.1

1.7

196.42

219.12

0.90

195

(3003577) Lead [Moles/volume] in Blood

2.68

1.99

1.3

1.0

0.11

0.10

umol/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

475

0.64

1.99

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

262

0.52

1.97

2.4

2.2

4.12

755.48

ug/l

1.03

262

(3022689) Creatine [Moles/volume] in Urine

293

0.55

1.96

1.2

1.3

6.51

6.75

mmol/l

0.10

293

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

2.41

1.96

1.4

1.3

16.57

15.45

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

579

0.68

1.96

1.1

94.44

90.94

0.53

521

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

195

0.45

1.91

1.0

1.3

116.00

113.00

—

170

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

259

0.53

1.91

1.2

1.3

—

1570418.09

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

651

0.70

1.90

1.4

1.5

6.44

6.79

u/l

0.06

504

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

379

3483

0.87

1.87

1.6

—

(3016750) Collection duration of Urine

667

0.71

1.86

1.9

2.0

486.05

501.87

min

0.43

462

(3021901) Oxygen saturation in Capillary blood

332

3078

0.86

1.86

2.4

3.1

88.12

88.53

0.51

321

2989

(3000093) Morphology [Interpretation] in Blood Narrative

129

1303

0.79

1.83

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

445

0.65

1.82

1.8

1.9

221.68

241.75

e6/l

0.28

404

(3024891) Influenza virus A+B Ag [Presence] in Specimen

298

2062

1.17

1.82

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

526

4724

0.89

1.81

2.4

3.1

24.75

24.92

mmol/l

0.50

512

4634

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

625

0.71

1.80

1.1

86.68

88.98

u/l

0.09

538

(3001964) Herpes simplex virus Ag [Presence] in Specimen

243

0.53

1.79

1.1

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

274

0.56

1.79

1.3

27.77

49.40

g/l

0.53

224

(3008295) Osmolality of Serum or Plasma

196

1310

1.21

1.78

1.2

1.3

277.23

273.62

mosm/kgh2o

0.95

131

947

(4195642) Thrombophilia screening test

726

0.73

1.78

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

547

0.69

1.76

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

253

2380

0.85

1.74

1.4

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1326

9989

1.08

1.72

3.0

2.6

0.54

0.52

e6/l

0.15

1279

9676

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

618

0.71

1.70

1.1

28.36

29.26

u/l

0.05

528

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1321

9955

1.07

1.70

2.3

3.7

81.64

100.61

ng/l

17.76

1027

8246

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

131

0.43

1.69

1.3

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

474

0.68

1.67

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

445

0.67

1.67

5.1

6.3

40.16

141.25

ug/l

0.76

277

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1615

12267

1.07

1.66

4.8

5.5

35.01

34.27

1.61

940

7584

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

444

0.67

1.65

1.8

400.61

496.37

e6/l

0.68

374

(3027035) Albumin [Mass/time] in 24 hour Urine

108

0.37

1.64

1.6

1.3

—

963.11

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

305

0.61

1.61

1.3

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

373

0.65

1.60

1.4

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

969

7236

1.08

1.60

3.1

4.3

42.67

45.34

3.04

956

7131

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

274

0.59

1.59

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

274

0.59

1.59

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

274

0.59

1.59

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

274

0.59

1.59

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

142

0.45

1.59

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1.76

1.59

9.7

10.7

639.86

758.78

nmol/l

0.53

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

957

0.78

1.59

1.1

78.21

543.82

iu/ml

0.74

147

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

447

1.33

1.59

1.1

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

180

0.49

1.58

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

459

3308

1.12

1.58

2.1

2.3

127.53

124.95

g/l

1.50

388

2556

(3006315) Basophils [#/volume] in Blood

5915

48703

0.96

1.56

4.3

5.8

0.04

e9/l

1.72

4953

40602

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

755

0.76

1.56

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

900

0.78

1.56

1.3

10.51

12.92

u/l

0.94

704

(40761536) Microorganisms panel - Urine sediment

1070

8031

1.08

1.55

4.7

4.8

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

1.54

0.0

4.3

—

0.00

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

178

0.50

1.53

1.1

—

1.60

—

(3034891) Synovial lining cells/cells in Synovial fluid

531

0.71

1.53

1.3

1.5

4.27

3.36

0.21

112

(37208534) Antinuclear antibody arbitrary concentration in serum

240

0.57

1.53

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

149

0.49

1.52

1.0

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

136

1333

0.82

1.52

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

219

0.55

1.52

1.1

1.4

95.03

147.98

pmol/l

1.30

219

(3026726) Creatinine [Moles/volume] in Specimen

102

0.39

1.52

1.0

2.6

69.60

399.33

umol/l

—

(3023183) Ammonium ion [Moles/volume] in Plasma

326

2308

1.14

1.51

1.5

1.9

24.50

32.01

umol/l

11.70

257

1973

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

187

0.52

1.50

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

173

1166

1.20

1.49

2.4

2.3

2.29

1.66

u/field

1.04

102

610

(3000285) Sodium [Moles/volume] in Blood

280

1.41

1.48

1.5

1.3

139.72

138.07

mmol/l

2.44

239

(3045414) Leukocytes [Presence] in Urine

1377

10448

1.07

1.48

2.1

2.2

0.00

0.01

estimate

2.03

172

1782

(3002079) Sodium [Moles/time] in 24 hour Urine

327

0.64

1.48

1.1

1.2

153.19

150.82

mmol/24h

0.04

327

(3018405) Lactate [Moles/volume] in Arterial blood

601

4413

1.10

1.47

2.7

3.6

1.42

1.41

mmol/l

0.04

589

4318

(3013115) Eosinophils [#/volume] in Blood

6062

49845

0.96

1.47

4.4

6.0

0.20

e9/l

0.16

5122

42150

(3024354) Oxygen [Partial pressure] in Venous blood

1535

11691

1.06

1.47

2.2

3.1

4.07

4.32

kpa

6.08

1491

11340

(3032773) Endomysium IgG Ab [Titer] in Serum

616

1.27

1.47

1.0

1.1

—

(40758558) Short blood count panel - Blood

3685

28714

1.04

1.45

5.0

6.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

123

0.46

1.45

3.9

1.4

75.14

56.54

pmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

124

1219

0.82

1.44

1.3

—

(3001604) Monocytes [#/volume] in Blood

5890

48441

0.96

1.43

4.3

5.8

0.64

e9/l

1.13

4924

40317

(3002030) Lymphocytes/Leukocytes in Blood

5563

45801

0.96

1.43

4.7

6.2

23.96

24.62

4.12

5128

42842

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

463

1.30

1.42

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

145

0.50

1.41

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

275

2521

0.88

1.39

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

502

0.72

1.39

1.2

1.1

0.25

0.91

u/ml

3.70

280

(3023430) Cat dander IgE Ab [Units/volume] in Serum

241

0.60

1.35

1.1

3.19

1.10

u/ml

—

121

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

328

1.35

1.33

1.1

300.64

321.20

mg/l

0.37

288

(3020393) Adenovirus Ag [Presence] in Stool

1.68

1.32

1.1

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

239

0.61

1.31

1.6

1.3

87.78

344.22

nmol/24h

1.28

239

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

106

1046

0.81

1.31

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

140

0.52

1.30

1.0

1.4

20.67

16.48

mm/h

—

140

(3039443) Prostate specific Ag panel - Serum or Plasma

732

0.78

1.29

1.5

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

606

1.25

1.29

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

606

1.25

1.29

1.1

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

110

1079

0.82

1.29

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

304

0.66

1.25

1.6

1.3

30.53

29.47

umol/l

0.24

284

(3017569) Oxygen content in Arterial blood

863

0.80

1.25

2.0

2.1

16.40

15.49

2.23

863

(1617658) Protocol used for examination of sentinel lymph nodes

629

0.77

1.25

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

123

1.57

1.25

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

639

4748

1.09

1.25

2.4

3.2

4.34

4.27

pmol/l

0.97

536

4082

(3038071) Oxygen [Partial pressure] in Mixed venous blood

185

0.56

1.24

5.0

8.0

9.04

5.60

kpa

0.94

185

(3028717) Thiamine [Mass/volume] in Blood

1.64

1.24

1.1

63.80

62.98

ug/l

0.06

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

113

1100

0.83

1.24

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

153

0.53

1.22

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

371

3308

0.90

1.22

1.3

1.4

267.54

255.54

ug/g

0.55

207

2051

(3000330) Specific gravity of Urine by Test strip

866

6520

1.07

1.21

4.0

4.3

1.02

ratio

2.10

773

5914

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

313

1.34

1.21

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

1.18

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.17

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

105

0.46

1.17

1.0

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

181

0.58

1.16

1.1

1.3

64.00

77.90

—

101

(3007853) Bacteria identified in Skin by Aerobe culture

1638

12594

1.05

1.16

1.7

1.9

—

(3022096) Basophils/Leukocytes in Blood

5517

45296

0.97

1.16

4.6

6.2

0.60

0.62

1.93

4994

41885

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

125

0.51

1.15

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

180

0.58

1.14

1.1

1.2

68.40

80.41

—

(3052851) Hemolysis interference index of Serum or Plasma

396

3501

0.91

1.12

3.5

3.7

1.92

1.85

index

0.09

190

1800

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

324

0.69

1.12

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

148

1016

1.17

1.11

1.3

522.27

421.78

titre

0.16

101

(3019198) Lymphocytes [#/volume] in Blood

6027

49381

0.97

1.10

4.4

5.9

1.73

1.83

e9/l

2.32

5148

42128

(3003888) Timothy IgE Ab [Units/volume] in Serum

407

0.73

1.10

1.0

1.15

1.57

u/ml

0.19

184

(3016038) Potassium [Moles/volume] in Urine

141

965

1.18

1.10

1.1

32.40

35.21

mmol/l

0.89

112

815

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

112

1074

0.84

1.08

1.3

1.4

—

(3019069) Monocytes/Leukocytes in Blood

5534

45389

0.97

1.08

4.6

6.2

9.19

9.25

0.84

5013

41909

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

209

1.39

1.06

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6706

54830

0.97

1.06

5.8

8.9

4.67

4.51

e9/l

4.48

5693

46707

(3020961) Endomysium IgA Ab [Titer] in Serum

401

2944

1.10

1.06

1.1

297.73

208.72

titre

0.32

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

142

1.47

1.06

1.7

1.8

1.42

1.16

ug/l

0.29

132

(3010726) Horse dander IgE Ab [Units/volume] in Serum

301

0.69

1.05

1.0

1.1

0.26

0.35

u/ml

0.24

173

(3010838) Calcium [Moles/time] in 24 hour Urine

168

1553

0.87

1.04

1.6

1.7

4.16

4.27

mmol/24h

0.16

128

1293

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

488

1.24

1.01

1.1

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

572

0.79

1.00

3.9

3.2

0.79

1.24

1.93

572

(3006504) Eosinophils/Leukocytes in Blood

5525

45276

0.97

1.00

4.5

6.1

2.76

2.78

0.17

5002

41832

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2345

19498

0.96

1.00

2.0

2.7

19.97

20.54

1.32

2023

17883

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1629

12582

1.05

0.99

4.4

6.9

120.20

118.26

g/l

3.72

1587

12283

(40762887) Creatinine [Moles/volume] in Blood

1.57

0.98

1.4

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

177

1247

1.14

0.98

1.8

1.6

28.49

26.90

u/ml

0.17

247

(3008401) Mugwort IgE Ab [Units/volume] in Serum

397

0.75

0.97

1.0

0.56

0.99

u/ml

—

172

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.54

0.96

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

790

5991

1.06

0.95

1.6

1.9

2.53

2.24

ug/l

0.17

597

5210

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

229

1.34

0.93

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

314

1.28

0.92

1.5

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1159

9767

0.95

0.91

2.2

2.4

62.97

38.40

u/l

0.57

946

8154

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.49

0.90

1.0

1.1

—

(3022313) Gas panel - Capillary blood

671

5739

0.94

0.89

2.8

4.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

149

1370

0.87

0.89

1.4

1.5

70.91

63.59

1.89

101

838

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

314

2765

0.91

0.88

2.1

2.2

69.93

105.65

ug/min

1.24

158

1531

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

115

1076

0.86

0.87

1.4

1.7

61.31

50.24

nmol/l

2.90

108

1018

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1097

8422

1.05

0.87

1.8

2.2

396.31

396.40

nmol/l

0.00

951

7650

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

399

0.77

0.87

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

141

989

1.15

0.86

1.3

24.44

65.97

titre

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

250

0.71

0.85

1.0

1.1

1.17

1.75

u/ml

—

134

(40767503) Oxygen content in Capillary blood by calculation

324

2842

0.92

0.84

2.4

2.7

16.35

15.67

4.09

315

2780

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.52

0.84

6.3

5.0

18.67

55.43

ug/min

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

546

0.81

1.2

1.3

523.40

254.58

ug/l

0.25

294

(3034274) Bile acid [Moles/volume] in Serum --fasting

378

1.24

0.81

1.2

1.3

10.30

14.33

umol/l

0.39

258

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

826

0.85

0.81

1.5

1.8

172.70

185.39

pmol/l

0.83

749

(3034426) Prothrombin time (PT)

172

0.65

0.81

1.1

1.2

28.64

27.97

0.20

172

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

124

1.43

0.80

3.8

5.7

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.80

0.0

1.0

—

0.73

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

668

0.83

0.80

1.2

8.00

8.06

mmol/l

0.05

517

(3010421) pH of Blood

465

4008

0.93

0.80

2.5

3.9

7.41

0.83

453

3936

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

307

1.26

0.79

1.1

44.30

512.62

ng/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.01

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

543

0.81

0.78

1.0

1.1

7.47

11.41

nmol/l

—

118

(3034092) Cytoplasmic Ig cells/cells in Blood

1.52

0.77

11.5

13.2

0.24

0.26

0.19

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

522

4473

0.94

0.77

1.2

1.3

48.53

57.92

au/ml

0.44

296

(3021788) Differential panel - Synovial fluid

242

2139

0.91

0.77

1.5

—

1.00

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.79

0.76

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

803

0.85

0.76

1.7

101.48

112.72

ng/l

0.72

803

(3023520) Reticulocytes [#/volume] in Blood

1736

13518

1.04

0.75

2.0

2.4

64.28

66.88

e9/l

2.44

1322

10014

(3025941) Bacteria identified in Stool by Culture

588

4460

1.06

0.75

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

298

0.76

0.74

2.0

3.0

—

59.45

—

(4198724) Urine methamphetamine measurement

1.61

0.74

1.1

1.0

—

(4133840) Spirometry

139

0.64

0.73

1.1

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

867

6656

1.05

0.73

2.6

3.5

25.40

25.13

mmol/l

1.66

829

6459

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.01

0.72

1.4

1.0

33.46

60.80

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

186

0.69

0.72

1.6

1.8

9.68

10.40

ug/l

0.36

186

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

223

0.72

1.3

1.1

1819.40

1614.94

miu/ml

0.33

223

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2033

16828

0.97

0.71

1.2

1.3

1.59

1.68

u/ml

0.11

464

3867

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

754

0.85

0.71

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

157

0.67

0.71

1.0

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

534

0.83

0.69

1.5

1.8

36.73

39.49

g/l

2.90

534

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

146

0.66

0.68

5.4

7.1

12.17

10.03

1.15

146

(3018010) Neutrophils/Leukocytes in Blood

5480

44715

0.98

0.68

4.6

6.1

60.61

59.80

4.88

5058

42191

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

181

1609

0.90

0.67

1.3

0.81

0.84

nmol/l

0.17

145

1327

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.64

0.66

1.4

1.8

13.78

17.37

umol/l

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

114

1040

0.88

0.66

1.4

1.5

19.62

26.86

2.22

640

(3014148) Varicella zoster virus Ab [Titer] in Serum

452

0.82

0.66

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

294

1.23

0.65

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

229

1.27

0.65

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

191

0.72

0.65

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

191

0.72

0.65

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.75

0.64

1.6

1.9

153.80

342.13

nmol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

102

934

0.88

0.64

1.6

1.4

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

332

1.21

0.63

1.3

1.4

73.34

61.73

2.17

286

(3050794) Legionella sp Ab [Presence] in Serum

0.59

0.63

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

554

0.84

0.63

1.7

2.2

—

(3024263) Appearance of Synovial fluid

555

1.16

0.62

1.4

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

334

0.79

0.62

1.1

4.79

13.13

iu/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.57

0.62

1.2

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

198

0.73

0.61

1.2

56.12

72.84

mu/l

—

135

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.61

0.0

1.1

—

8.31

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

113

0.64

0.61

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

0.55

—

(36303858) Crystals [Presence] in Urine

0.00

0.61

0.0

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.61

0.0

6.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

132

1.34

0.60

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.7

—

1.34

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1094

8491

1.04

0.60

2.4

3.2

128.34

125.24

g/l

5.52

1066

8239

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

927

7171

1.04

0.60

1.9

2.6

1.10

1.12

0.42

920

7139

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

225

1.25

0.59

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

145

1293

0.90

0.59

3.6

3.9

—

(3027315) Oxygen [Partial pressure] in Blood

317

2730

0.93

0.59

2.9

4.4

8.25

8.27

kpa

0.05

304

2649

(4015189) Microbial culture of sputum

331

0.80

0.59

2.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.62

0.58

1.3

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

233

1.24

0.58

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

255

1.23

0.58

1.0

1.1

1.11

1.20

u/l

0.64

124

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

336

1.20

0.57

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

145

1289

0.90

0.57

3.6

3.5

10.74

12.16

index

1.05

668

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

144

1280

0.90

0.57

1.4

1.6

5.72

4.90

mg/l

0.28

114

1011

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

191

1.26

0.56

1.2

1.3

99.96

102.90

ug/l

0.05

118

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.49

0.56

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

1.35

0.56

1.0

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

894

7468

0.96

0.55

2.0

3.6

24.31

24.14

mmol/l

0.87

875

7336

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

496

1.15

0.53

3.5

2.8

224.63

218.39

u/l

0.27

489

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

110

0.66

0.52

1.0

3.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.42

0.52

1.9

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.51

0.51

1.5

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

421

0.84

0.51

1.2

41.84

40.20

g/l

0.59

196

(3022493) Free Hemoglobin [Mass/volume] in Plasma

516

0.86

0.51

1.1

2.2

62.53

66.13

mg/l

0.19

337

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1036

8613

0.97

0.51

2.7

3.9

5.15

5.16

kpa

0.06

924

8128

(3003740) Influenza virus B Ag [Presence] in Specimen

429

0.84

0.51

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

289

0.81

0.51

1.3

—

(3004451) EKG impression Narrative

874

0.89

0.51

1.2

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

282

1.20

0.50

2.1

2.5

6.94

7.46

mmol/l

0.91

195

(3023383) Lactate [Moles/volume] in Pleural fluid

540

0.86

0.49

1.3

4.00

3.24

mmol/l

0.82

496

(3044927) Protein electrophoresis panel - Urine

206

1536

1.08

0.49

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

137

1.29

0.49

3.0

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

318

2715

0.94

0.49

2.9

4.4

4.87

5.02

kpa

3.28

306

2634

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

340

0.83

0.49

1.0

1.2

7.83

14.07

pmol/l

—

121

(3001729) Color of Synovial fluid

109

1.33

0.49

1.8

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.48

1.0

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.63

0.48

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

403

1.16

0.48

8.0

5.6

63.46

72.06

1.32

303

(3012501) Base excess in Blood by calculation

318

2713

0.94

0.48

2.9

4.4

2.08

2.85

mmol/l

7.10

209

1879

(3002523) Influenza virus A Ag [Presence] in Specimen

426

0.85

0.48

1.1

—

(44806420) Estimation of glomerular filtration rate

572

0.87

0.47

2.5

2.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

423

3238

1.05

0.47

1.0

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

915

7124

1.04

0.46

1.9

2.6

0.65

0.63

910

7098

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.59

0.46

1.2

1.0

—

(3002619) Bacteria identified in Specimen by Culture

278

1.19

0.46

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

603

0.88

0.45

1.0

1.1

3.59

4.46

eliau/ml

0.15

106

(3041918) Cholesterol [Moles/volume] in Pleural fluid

310

0.83

0.44

1.2

1.39

1.42

mmol/l

0.04

192

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

754

0.90

0.43

1.1

1.2

100.87

99.44

pmol/l

0.10

754

(3009343) pH of Capillary blood

1013

8392

0.97

0.43

2.7

3.9

7.42

0.81

834

7044

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

220

0.80

0.42

1.2

1.1

231.08

275.07

pmol/l

0.40

150

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

371

3134

0.95

0.42

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.42

0.0

1.1

—

(3013862) HLA-DP [Type]

0.00

0.42

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.41

0.0

4.8

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

194.60

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

0.41

0.0

7.8

—

55.60

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.41

0.0

1.2

—

1.69

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.41

0.0

1.1

—

149.04

—

(3043410) Blood group antigens tested for on Red Blood Cells

359

0.85

0.41

1.7

2.0

—

(3041354) Potassium [Moles/volume] in Venous blood

231

1977

0.94

0.41

2.2

2.6

4.10

4.12

mmol/l

0.37

226

1962

(3035285) Chloride [Moles/volume] in Venous blood

231

1977

0.94

0.41

2.2

2.6

106.28

105.47

mmol/l

1.31

226

1961

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

877

0.91

0.41

1.2

1.25

1.47

nmol/l

2.06

787

(3014891) Appearance of Pleural fluid

289

0.83

0.40

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.40

0.0

1.5

—

127.75

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3431

27977

0.98

0.40

2.5

3.1

34.97

36.58

u/l

0.37

3166

26007

(3046861) Legionella sp Ag [Presence] in Urine

0.69

0.40

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

229

1957

0.94

0.39

2.2

2.6

1.20

mmol/l

0.09

224

1942

(3000060) B lymphocytes [#/volume] in Blood

120

0.74

0.39

1.9

1.7

0.11

1.83

e9/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.34

0.38

1.1

6.17

6.21

mmol/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

119

0.74

0.38

1.0

1.1

16.80

21.89

iu/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

119

0.74

0.38

2.1

1.5

—

(3045424) Erythrocytes [Presence] in Urine

663

5161

1.04

0.37

1.9

2.2

0.00

0.21

estimate

0.57

132

1293

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

270

1.16

0.37

1.3

24.08

32.32

0.84

169

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

414

0.87

0.36

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

269

2054

1.05

0.36

1.5

1.7

3.11

16.22

iu/l

0.77

672

(44806118) Parainfluenza type 4 nucleic acid detection

147

1270

0.93

0.36

1.3

—

(3016502) Oxygen saturation in Arterial blood

1761

13905

1.02

0.36

4.2

6.4

95.07

95.04

0.06

1692

13370

(3045683) HLA typing for celiac disease panel - Blood or Tissue

233

1.17

0.36

1.1

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

456

0.88

0.36

1.3

1.4

36.25

32.27

iu/l

0.30

387

(3022948) Iron [Moles/volume] in Serum or Plasma

2786

22102

1.02

0.35

2.0

2.7

10.86

11.36

umol/l

3.43

2405

20279

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.62

0.35

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.39

0.35

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

109

952

0.92

0.35

2.5

3.1

27.87

34.13

mg/l

0.21

712

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.42

0.35

1.5

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

825

6824

0.97

0.35

2.5

2.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

471

0.89

0.34

1.0

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

170

0.80

0.34

1.1

1.2

16.20

17.56

u/l

—

109

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

381

3193

0.96

0.34

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

421

3258

1.04

0.34

1.3

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

152

0.79

0.33

1.0

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

291

0.86

0.33

1.2

1.3

42.68

1145.23

u/l

—

(3020891) Body temperature

791

6192

1.03

0.33

3.1

4.2

36.92

36.90

°c

1.10

778

6121

(44790049) Parainfluenza type 3 nucleic acid detection

148

1270

0.94

0.32

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

148

1270

0.94

0.32

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

148

1270

0.94

0.32

1.3

—

(4212803) Bone marrow aspirate examination

132

0.79

0.30

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

219

0.84

0.30

1.4

1.3

26.21

22.33

0.18

169

(3028433) Virus identified in Specimen by Culture

296

0.87

0.29

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

175

0.83

0.29

1.1

1.0

12.00

30.33

u/ml

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

329

0.88

0.28

1.5

1.6

7.34

7.58

nmol/l

0.02

285

(40757494) Bilirubin.total [Moles/volume] in Blood

592

1.09

0.28

1.6

2.1

16.49

24.24

umol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

134

1.20

0.28

2.7

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.21

0.27

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1421

11623

0.98

0.26

2.1

2.5

8.49

10.48

umol/l

3.21

1190

10218

(40762814) Titanium [Mass/volume] in Blood

233

0.86

0.26

2.0

2.2

2.89

3.48

ug/l

0.84

(1761482) Bacteria [#/volume] in Urine by Culture

448

3715

0.97

0.26

4.8

5.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

349

1.11

0.25

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1349

10679

1.02

0.25

1.6

2.0

0.20

0.19

g/l

1.54

1183

9783

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

189

1.15

0.24

1.1

—

(3013512) EKG study

4752

38509

0.99

0.24

4.4

4.5

0.86

0.73

0.61

107

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

459

0.91

0.24

1.1

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

486

3803

1.03

0.24

2.9

3.7

1.68

1.64

mmol/l

0.39

475

3720

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

197

0.86

0.24

1.2

1.4

79.30

73.98

0.34

165

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

272

0.89

0.22

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.24

0.22

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.24

0.22

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.24

0.22

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

263

0.89

0.22

3.4

5.9

9.66

8.51

mmol/l

1.37

263

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.22

0.22

1.6

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.0

—

329.78

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

555

4362

1.02

0.21

2.9

4.3

25.09

24.90

mmol/l

0.72

456

3893

(3030313) Adrenal Ab [Titer] in Serum

1.18

0.21

1.0

1.1

—

12.67

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.2

—

3.52

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

314.70

—

(3012544) pH of Venous blood

1770

14069

1.01

0.21

2.4

3.6

7.38

3.40

1040

8419

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

102.20

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

275.26

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

253

0.89

0.20

1.3

1.19

1.18

mmol/l

0.44

253

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

454

0.92

0.20

1.1

1.2

—

(36660697) Celiac disease serology panel - Serum

763

6024

1.02

0.20

1.2

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

162

1.14

0.20

8.3

7.7

13.67

13.65

0.02

162

(4146454) Self-monitoring of blood glucose

175

1351

1.04

0.20

2.7

2.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2565

20827

0.99

0.20

2.0

2.7

2.21

2.23

g/l

0.89

2215

18994

(3006442) Creatine [Moles/volume] in Serum or Plasma

550

1.07

0.19

2.0

1.8

88.40

98.93

umol/l

1.58

550

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2556

20749

0.99

0.19

1.5

1.7

1.76

1.65

mg/l

0.70

1966

16636

(3029396) Erythrocyte agglutination [Presence] in Blood

1.15

0.19

2.0

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2281

18527

0.99

0.19

1.6

1.9

29.57

30.07

3.35

2188

18009

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

192

0.88

0.18

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

192

0.88

0.18

1.3

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

110

1.17

0.18

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

175

1463

0.96

0.18

1.2

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

233

1.11

0.18

1.0

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1752

13948

1.01

0.18

2.3

3.6

5.82

5.83

kpa

0.17

1702

13574

(3024869) Neuronal Ab [Presence] in Serum

208

0.89

0.17

1.0

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

498

1.07

0.17

1.3

1.5

13.33

15.33

umol/l

1.66

459

(3027944) Amphetamines [Presence] in Urine

199

0.89

0.17

2.5

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

273

1.09

0.16

1.5

0.39

0.38

ug/l

0.03

154

(3025577) Chromium [Mass/volume] in Blood

104

798

1.05

0.16

1.9

2.1

2.03

2.22

ug/l

0.37

659

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.22

0.16

2.9

5.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2599

21073

0.99

0.16

3.3

3.7

0.85

0.88

ug/l

0.38

1873

15815

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

257

0.91

0.16

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

215

0.90

0.16

1.1

0.52

0.66

umol/24h

1.28

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.13

0.16

1.0

1.1

13.64

29.00

iu/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.11

0.16

1.1

96.00

112.00

titre

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

521

0.94

0.15

1.2

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

173

1436

0.97

0.14

1.2

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

136

1.12

0.14

1.2

1.1

—

(3003396) Base excess in Arterial blood by calculation

1943

15507

1.01

0.14

4.1

6.2

1.33

0.98

mmol/l

3.32

1497

12613

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

876

7138

0.99

0.14

5.3

8.3

15.74

15.64

0.53

834

6884

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

171

1419

0.97

0.14

1.2

1.4

—

(3049717) Cytology report of Urine Cyto stain

712

5654

1.01

0.12

2.9

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

207

1.09

0.12

1.6

1.2

1.38

25.47

mg/l

0.48

159

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

111

0.87

0.12

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.15

0.11

2.2

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

351

2874

0.98

0.11

1.6

16662.88

15131.67

e6/l

0.24

259

1969

(3025549) Creatine [Moles/time] in 24 hour Urine

0.87

0.11

1.6

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

163

1346

0.97

0.11

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

162

1.09

0.11

2.7

2.4

0.69

0.66

ug/l

0.13

162

(3028679) Herpes simplex virus Ab [Presence] in Serum

267

0.93

0.10

1.0

1.1

—

(4211845) Urine protein measurement

548

1.04

0.10

3.8

4.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

113

881

1.03

0.10

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.09

0.09

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

241

0.93

0.09

1.1

1.2

0.54

1.60

mmol/l

1.43

151

(3024928) Oxygen saturation in Venous blood

382

3117

0.99

0.09

1.6

2.5

56.66

57.84

0.44

356

2966

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

140

1.09

0.09

1.2

1.1

—

(3002032) Base excess in Venous blood by calculation

1695

13557

1.01

0.09

2.3

3.6

2.01

1.82

mmol/l

1.47

1485

11721

(3009015) Lactate [Moles/volume] in Synovial fluid

133

0.91

0.09

1.1

1.2

7.15

6.54

mmol/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

145

1194

0.98

0.08

2.5

2.9

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.05

0.08

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.08

0.08

1.0

—

(3037121) Protein [Mass/volume] in Urine

505

4106

0.99

0.08

2.3

2.9

1301.71

699.60

mg/l

0.25

144

1735

(3020491) Glucose [Moles/volume] in Blood

696

1.03

0.07

1.5

2.3

7.90

7.26

mmol/l

0.70

478

(3001019) Free T4 and TSH panel - Serum or Plasma

768

1.03

0.07

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.84

0.07

1.4

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

222

0.94

0.07

1.2

36.65

199.78

u/l

0.58

149

(3025468) Yersinia sp identified in Specimen by Organism specific culture

167

1368

0.98

0.07

1.1

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

140

1104

1.02

0.07

1.2

1.4

202437.51

191867.46

e6/l

0.05

730

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.02

0.07

1.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

762

1.02

0.06

2.1

1.9

340.43

308.87

mu/l

0.28

696

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.88

0.06

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

261

1.05

0.06

1.3

1.4

0.14

nmol/l

0.01

180

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

180

0.94

0.06

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

196

0.94

0.06

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.12

0.06

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

611

4945

0.99

0.04

2.2

2.5

32.30

23.49

au/ml

0.54

307

(40761539) Cells [Type] in Urine sediment by Light microscopy

300

0.97

0.04

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

255

2071

0.99

0.04

1.3

1.4

0.26

0.28

mg/l

0.22

107

764

(3035320) C reactive protein [Mass/volume] in Body fluid

786

0.98

0.04

2.9

3.0

35.19

31.55

mg/l

0.37

609

(3026470) Cobalt [Mass/volume] in Blood

105

831

1.02

0.04

1.9

2.0

3.81

4.08

ug/l

0.16

763

(3038515) Glucose [Moles/volume] in Venous blood

411

3285

1.01

0.04

3.1

3.8

7.96

7.73

mmol/l

0.70

402

3213

(3020650) Glucose [Presence] in Urine

258

0.97

0.03

2.1

1.8

0.00

0.03

estimate

1.08

258

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

241

1.03

0.03

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

201

0.96

0.03

2.4

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

256

2045

1.01

0.03

1.8

1.9

1.82

1.71

mmol/l

1.25

250

1981

(3017704) Immunofixation for Urine

100

794

1.01

0.03

1.3

1.4

—

(3006462) Nitrate [Presence] in Urine

506

1.02

0.02

3.8

4.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

146

1.05

0.02

1.3

1.7

41.21

48.05

umol/l

0.58

146

(3019977) pH of Arterial blood

1941

15591

1.00

0.02

4.2

6.2

7.42

1.35

1238

8656

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

127

0.95

0.02

1.0

1.2

174.91

887.35

ng/l

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1938

15613

1.00

0.02

4.2

6.2

11.51

11.68

kpa

0.74

1844

14882

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1939

15621

1.00

0.02

4.2

6.2

4.96

5.06

kpa

4.10

1846

14897

(3026051) Granulocytes/Leukocytes in Pleural fluid

369

0.98

0.01

1.3

1.4

17.97

21.68

0.46

303

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.07

0.01

1.2

1.1

11.00

11.46

u/l

0.05

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

169

1368

0.99

0.01

1.2

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

268

1.02

0.01

1.1

1.3

105.88

132.94

nmol/l

0.66

187

(3028300) Cannabinoids [Presence] in Urine

206

0.98

0.00

2.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

317

1.02

0.00

1.7

1.9

337.24

340.18

mu/l

0.02

240

(3014111) Lactate [Moles/volume] in Serum or Plasma

1454

11703

1.00

0.00

3.7

6.0

1.50

1.39

mmol/l

3.45

1419

11397

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.98

0.00

1.0

1.1

1.80

1.66

umol/24h

0.28

(3005011) Chlamydia sp Ab [Titer] in Serum

1.01

0.00

1.9

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.96

0.00

1.0

1.1

—

195.00

—

(3000764) Benzodiazepines [Presence] in Urine

200

1.01

0.00

2.3

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

348

0.99

0.00

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

205

0.98

0.00

2.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

172

0.98

0.00

2.5

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

170

1371

1.00

0.00

1.2

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

923

7430

1.00

0.00

2.6

3.7

1.92

2.11

mmol/l

0.89

646

5466

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.89

-0.00

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

341.20

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.84

-0.00

1.0

1.1

0.10

0.03

u/ml

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

303.83

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.98

-0.00

2.0

1.2

—

1.25

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.6

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.01

-0.00

1.2

1.1

178.40

268.73

nmol/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

-0.00

0.0

7.1

—

6.49

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

26.40

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.95

-0.00

1.1

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.92

-0.00

1.0

1.4

104.14

140.85

ug/l

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.00

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.86

-0.00

1.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.00

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

31.00

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.8

—

8.88

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

3188.63

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

3.75

—

(44806071) Cardiolipin IgM antibody measurement

0.98

-0.00

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.8

—

5.67

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ADMED_OTHER_ANTI_DEMENTIA_DRUGS – Use of other anti-dementia drugs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Use of other anti-dementia drugs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Use of other anti-dementia drugs (ADMED_OTHER_ANTI_DEMENTIA_DRUGS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints